Pei Hui, PhD, MD
Biography
Pei Hui, MD, PhD, is a pathologist who specializes in gynecological diseases and cancers, including endometrial, ovarian, and fallopian tube cancers.
“You understand disease better through pathology,” Dr. Hui says. “You learn how it develops and its mechanisms at a cellular and molecular level.”
Dr. Hui points out that although pathologists rarely see patients face-to-face, they are still in charge of the well-being of the patient through the microscopic diagnosis. “We look at 30 to 50 cases each day, so in a way you could say that we see more patients than any other physician,” he says.
Dr. Hui says that he enjoys working as a team to provide better care for patients. For example, on any given day, he might be talking via phone, email, or text, to a patient’s oncologist or doctor. “We are informative for them because we provide timely and accurate diagnosis and using new biomarkers that may change the patient treatment options. The boundary between physician and pathologist is smaller than ever.”
What most excites Dr. Hui is the ability to improve diagnostic accuracy and find new biomarkers to guide clinical management for patients and prognosis. He continues his research in that area as professor and director of gynecologic pathology at Yale School of Medicine.
Titles
- Professor of Pathology and of Obstetrics, Gynecology and Reproductive Sciences
- Director, Gynecologic Pathology
- Clinical Director, Molecular Diagnostics Laboratories
Education & Training
- FellowshipMemorial Sloan Kettering Cancer Center (2001)
- ResidencyYale School of Medicine (2000)
- PhDSUNY at Buffalo (1994)
- MSPeking University, Tumor Biology (1987)
- MDXian Medical University (1984)
Languages Spoken
- 官話 / 官话 (Chinese-Mandarin)
- English
Additional Information
- F. Stephen Vogel Award: United States and Canadian Academy of Pathology (2001)
- AB of Pathology, Molecular Genetic Pathology (2003)
- AB of Pathology, Anatomic & Clinical Pathology (2000)
- Stendahl K, Gilani SM, Basturk O, Hui P, Sigel C, Cai G. Intraductal papillary neoplasm of the bile duct: Cytomorphologic and molecular features. Cancer Cytopathology 2022 PMID: 36041224, DOI: 10.1002/cncy.22637.
- Yadav G, Roque DM, Bellone S, Manavella DD, Hartwich TMP, Zipponi M, Harold J, Tymon-Rosario J, Mutlu L, Altwerger G, Menderes G, Ratner E, Buza N, Hui P, Huang GS, Andikyan V, Clark M, Azodi M, Schwartz PE, Alexandrov LB, Santin AD. Synergistic activity of neratinib in combination with olaparib in uterine serous carcinoma overexpressing HER2/neu. Gynecologic Oncology 2022, 166: 351-357. PMID: 35641325, DOI: 10.1016/j.ygyno.2022.05.021.
- Sun T, Zuo T, Hui P, Cai G. Significance of KRAS mutation testing in biliary brushing cytology specimens: A 10-year retrospective review. Cancer Cytopathology 2022, 130: 558-565. PMID: 35417072, DOI: 10.1002/cncy.22579.
- Moriarty K, Yu M, Hussain N, Zgutka K, Sanders MM, Harigopal M, Wang J, Wang X, Hui P, Liu C, Sink D, Shields A. COVID-19 & differential effects in twins: Insights from Placenta Pathology. Placenta 2022, 124: 62-66. PMID: 35640456, PMCID: PMC9121647, DOI: 10.1016/j.placenta.2022.05.014.
- Buza N, Hui P. Characteristics of HER2 Gene Amplification by Fluorescence In Situ Hybridization in Endometrial Serous Carcinoma. Archives Of Pathology & Laboratory Medicine 2022, 146: 0. PMID: 35687792, DOI: 10.5858/arpa.2021-0547-OA.
- Beroukhim G, Ozgediz D, Cohen PJ, Hui P, Morotti R, Schwartz PE, Yang-Hartwich Y, Vash-Margita A. Progression of Cystadenoma to Mucinous Borderline Ovarian Tumor in Young Females: Case Series and Literature Review. Journal Of Pediatric And Adolescent Gynecology 2022, 35: 359-367. PMID: 34843973, DOI: 10.1016/j.jpag.2021.11.003.
- Roque DM, Siegel ER, Buza N, Bellone S, Silasi DA, Huang GS, Andikyan V, Clark M, Azodi M, Schwartz PE, Rao GG, Reader JC, Hui P, Tymon-Rosario JR, Harold J, Mauricio D, Zeybek B, Menderes G, Altwerger G, Ratner E, Santin AD. Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer. British Journal Of Cancer 2022, 126: 1695-1703. PMID: 35149854, PMCID: PMC8853032, DOI: 10.1038/s41416-022-01717-6.
- Petrone ME, Rothman JE, Breban MI, Ott IM, Russell A, Lasek-Nesselquist E, Badr H, Kelly K, Omerza G, Renzette N, Watkins AE, Kalinich CC, Alpert T, Brito AF, Earnest R, Tikhonova IR, Castaldi C, Kelly JP, Shudt M, Plitnick J, Schneider E, Murphy S, Neal C, Laszlo E, Altajar A, Pearson C, Muyombwe A, Downing R, Razeq J, Niccolai L, Wilson MS, Anderson ML, Wang J, Liu C, Hui P, Mane S, Taylor BP, Hanage WP, Landry ML, Peaper DR, Bilguvar K, Fauver JR, Vogels CBF, Gardner LM, Pitzer VE, St George K, Adams MD, Grubaugh ND. Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 variants Alpha and Iota. Communications Biology 2022, 5: 439. PMID: 35545661, PMCID: PMC9095641, DOI: 10.1038/s42003-022-03347-3.
- Hui P. Endometrial Polyp in Postmenopausal Women. Archives Of Pathology & Laboratory Medicine 2022 PMID: 35512230, DOI: 10.5858/arpa.2021-0557-RA.
- DeFina SM, Wang J, Yang L, Zhou H, Adams J, Cushing W, Tuohy B, Hui P, Liu C, Pham K. SaliVISION: a rapid saliva-based COVID-19 screening and diagnostic test with high sensitivity and specificity. Scientific Reports 2022, 12: 5729. PMID: 35388102, PMCID: PMC8986854, DOI: 10.1038/s41598-022-09718-4.
- Bellone S, Roque DM, Siegel ER, Buza N, Hui P, Bonazzoli E, Guglielmi A, Zammataro L, Nagarkatti N, Zaidi S, Lee J, Silasi DA, Huang GS, Andikyan V, Damast S, Clark M, Azodi M, Schwartz PE, Tymon-Rosario JR, Harold JA, Mauricio D, Zeybek B, Menderes G, Altwerger G, Ratner E, Alexandrov LB, Iwasaki A, Kong Y, Song E, Dong W, Elvin JA, Choi J, Santin AD. A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability. Cancer 2022, 128: 1206-1218. PMID: 34875107, DOI: 10.1002/cncr.34025.
- Li JY, Mutlu L, Tymon-Rosario J, Khadraoui W, Nagarkatti N, Hui P, Buza N, Lu L, Schwartz P, Menderes G. Clinicopathologic characteristics and oncologic outcomes in adenosarcoma of gynecologic sites. Gynecologic Oncology Reports 2022, 39: 100913. PMID: 35005157, PMCID: PMC8715286, DOI: 10.1016/j.gore.2021.100913.
- Pawlica P, Yario TA, White S, Wang J, Moss WN, Hui P, Vinetz JM, Steitz JA. SARS-CoV-2 expresses a microRNA-like small RNA able to selectively repress host genes. Proceedings Of The National Academy Of Sciences Of The United States Of America 2021, 118 PMID: 34903581, PMCID: PMC8719879, DOI: 10.1073/pnas.2116668118.
- Assem H, Rottmann D, Finkelstein A, Wang M, Ratner E, Santin AD, Buza N, Hui P. Minimal uterine serous carcinoma and endometrial polyp: a close clinicopathological relationship. Human Pathology 2021, 118: 1-8. PMID: 34508766, DOI: 10.1016/j.humpath.2021.09.001.
- Tymon-Rosario J, Bonazzoli E, Bellone S, Manzano A, Pelligra S, Guglielmi A, Gnutti B, Nagarkatti N, Zeybek B, Manara P, Zammataro L, Harold J, Mauricio D, Buza N, Hui P, Altwerger G, Menderes G, Ratner E, Clark M, Andikyan V, Huang GS, Silasi DA, Azodi M, Schwartz PE, Santin AD. DHES0815A, a novel antibody-drug conjugate targeting HER2/neu, is highly active against uterine serous carcinomas in vitro and in vivo. Gynecologic Oncology 2021, 163: 334-341. PMID: 34452746, PMCID: PMC8722447, DOI: 10.1016/j.ygyno.2021.08.014.
- Wang M, Hui P. A Timely Update of Immunohistochemistry and Molecular Classification in the Diagnosis and Risk Assessment of Endometrial Carcinomas. Archives Of Pathology & Laboratory Medicine 2021, 145: 1367-1378. PMID: 34673912, DOI: 10.5858/arpa.2021-0098-RA.
- Mackow NA, Abi-Raad R, Kerantzas CA, Hui P, Malinis M, Azar MM. Increased Detection of Mycobacterium tuberculosis Disease Using a Tissue-Based Laboratory-Developed Polymerase Chain Reaction Assay Compared to Standard Diagnostics. The American Journal Of Tropical Medicine And Hygiene 2021, 105: 1657-1661. PMID: 34544041, PMCID: PMC8641361, DOI: 10.4269/ajtmh.21-0104.
- Rottmann D, Assem H, Matsumoto N, Wong S, Hui P, Buza N. Does Specimen Type Have an Impact on HER2 Status in Endometrial Serous Carcinoma? Discordant HER2 Status of Paired Endometrial Biopsy and Hysterectomy Specimens in the Presence of Frequent Intratumoral Heterogeneity. International Journal Of Gynecological Pathology : Official Journal Of The International Society Of Gynecological Pathologists 2021, 40: 263-271. PMID: 32897955, DOI: 10.1097/PGP.0000000000000690.
- Tal R, Lawal T, Granger E, Simoni M, Hui P, Buza N, Pal L. Genital tuberculosis screening at an academic fertility center in the United States. American Journal Of Obstetrics And Gynecology 2020, 223: 737.e1-737.e10. PMID: 32497612, DOI: 10.1016/j.ajog.2020.05.045.
- Snir OL, DeJoseph M, Wu X, Rottmann D, Wong S, Buza N, Hui P. Lack of genetic homozygosity in prepubertal teratomas: divergent pathogenesis distinct from that of teratomas in adolescents. Laboratory Investigation; A Journal Of Technical Methods And Pathology 2020, 100: 1447-1454. PMID: 32694569, DOI: 10.1038/s41374-020-0468-6.
- Zheng XZ, Qin XY, Chen SW, Wang P, Zhan Y, Zhong PP, Buza N, Jin YL, Wu BQ, Hui P. Heterozygous/dispermic complete mole confers a significantly higher risk for post-molar gestational trophoblastic disease. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2020, 33: 1979-1988. PMID: 32404958, DOI: 10.1038/s41379-020-0566-4.
- Ordulu Z, Chai H, Peng G, McDonald AG, De Nictolis M, Garcia-Fernandez E, Hardisson D, Prat J, Li P, Hui P, Oliva E, Buza N. Molecular and clinicopathologic characterization of intravenous leiomyomatosis. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2020, 33: 1844-1860. PMID: 32341498, PMCID: PMC7483566, DOI: 10.1038/s41379-020-0546-8.
- Hui P. Germline NLRP7 mutations: genomic imprinting and hydatidiform mole. Virchows Archiv : An International Journal Of Pathology 2020, 477: 175-176. PMID: 32577811, DOI: 10.1007/s00428-020-02802-y.
- Fader AN, Roque DM, Siegel E, Buza N, Hui P, Abdelghany O, Chambers S, Secord AA, Havrilesky L, O'Malley DM, Backes FJ, Nevadunsky N, Edraki B, Pikaart D, Lowery W, ElSahwi K, Celano P, Bellone S, Azodi M, Litkouhi B, Ratner E, Silasi DA, Schwartz PE, Santin AD. Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis. Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research 2020, 26: 3928-3935. PMID: 32601075, PMCID: PMC8792803, DOI: 10.1158/1078-0432.CCR-20-0953.
- Wong S, Hui P, Buza N. Frequent loss of mutation-specific mismatch repair protein expression in nonneoplastic endometrium of Lynch syndrome patients. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2020, 33: 1172-1181. PMID: 31932681, DOI: 10.1038/s41379-020-0455-x.
- Simpson S, Simoni M, Hui P, Taylor H, Buza N. Extragonadal Yolk Sac Tumor Limited to the Myometrium: Report of a Case With Potential Fertility Preservation and Molecular Analysis Suggesting Germ Cell Origin. International Journal Of Gynecological Pathology : Official Journal Of The International Society Of Gynecological Pathologists 2020, 39: 247-253. PMID: 31033797, DOI: 10.1097/PGP.0000000000000601.
- Pelligra S, Buza N, Hui P, Bellone S, Zeybek B, Ratner E, Schwartz PE, Scambia G, Santin AD. Selection of HER2/NEU negative tumor cells as a mechanism of resistance to trastuzumab in uterine serous carcinoma. Gynecologic Oncology Reports 2020, 32: 100554. PMID: 32140533, PMCID: PMC7049633, DOI: 10.1016/j.gore.2020.100554.
- Chen PH, Hui P, Buza N. Bilateral Signet-ring Stromal Tumor of the Ovary: A Case Report With Next-generation Sequencing Analysis and FOXL2 Mutation Testing. International Journal Of Gynecological Pathology : Official Journal Of The International Society Of Gynecological Pathologists 2020, 39: 193-198. PMID: 30676431, DOI: 10.1097/PGP.0000000000000579.
- Perrone E, Manara P, Lopez S, Bellone S, Bonazzoli E, Manzano A, Zammataro L, Bianchi A, Zeybek B, Buza N, Tymon-Rosario J, Altwerger G, Han C, Menderes G, Huang GS, Ratner E, Silasi DA, Azodi M, Hui P, Schwartz PE, Scambia G, Santin AD. Sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2, shows cytotoxic activity against poorly differentiated endometrial adenocarcinomas in vitro and in vivo. Molecular Oncology 2020, 14: 645-656. PMID: 31891442, PMCID: PMC7053235, DOI: 10.1002/1878-0261.12627.
- Lopez S, Perrone E, Bellone S, Bonazzoli E, Zeybek B, Han C, Tymon-Rosario J, Altwerger G, Menderes G, Bianchi A, Zammataro L, Manzano A, Manara P, Ratner E, Silasi DA, Huang GS, Azodi M, Schwartz PE, Raspagliesi F, Angioli R, Buza N, Hui P, Bond HM, Santin AD. Preclinical activity of sacituzumab govitecan (IMMU-132) in uterine and ovarian carcinosarcomas. Oncotarget 2020, 11: 560-570. PMID: 32082489, PMCID: PMC7007291, DOI: 10.18632/oncotarget.27342.
- Han C, Perrone E, Zeybek B, Bellone S, Tymon-Rosario J, Altwerger G, Menderes G, Feinberg J, Haines K, Muller Karger ME, Bianchi A, Zammataro L, Manzano A, Bonazzoli E, Manara P, Buza N, Hui P, Ratner E, Silasi DA, Huang GS, Azodi M, Schwartz PE, Lopez S, Santin AD. In vitro and in vivo activity of sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (Trop-2) in uterine serous carcinoma. Gynecologic Oncology 2020, 156: 430-438. PMID: 31839338, DOI: 10.1016/j.ygyno.2019.11.018.
- Zeybek B, Manzano A, Bianchi A, Bonazzoli E, Bellone S, Buza N, Hui P, Lopez S, Perrone E, Manara P, Zammataro L, Altwerger G, Han C, Tymon-Rosario J, Menderes G, Ratner E, Silasi DA, Huang GS, Azodi M, Schwartz PE, Santin A. Cervical carcinomas that overexpress human trophoblast cell-surface marker (Trop-2) are highly sensitive to the antibody-drug conjugate sacituzumab govitecan. Scientific Reports 2020, 10: 973. PMID: 31969666, PMCID: PMC6976591, DOI: 10.1038/s41598-020-58009-3.
- Rottmann D, Snir OL, Wu X, Wong S, Hui P, Santin AD, Buza N. HER2 testing of gynecologic carcinosarcomas: tumor stratification for potential targeted therapy. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2020, 33: 118-127. PMID: 31477811, DOI: 10.1038/s41379-019-0358-x.
- Perrone E, Lopez S, Zeybek B, Bellone S, Bonazzoli E, Pelligra S, Zammataro L, Manzano A, Manara P, Bianchi A, Buza N, Tymon-Rosario J, Altwerger G, Han C, Menderes G, Ratner E, Silasi DA, Azodi M, Hui P, Schwartz PE, Scambia G, Santin AD. Preclinical Activity of Sacituzumab Govitecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) Linked to the Active Metabolite of Irinotecan (SN-38), in Ovarian Cancer. Frontiers In Oncology 2020, 10: 118. PMID: 32117765, PMCID: PMC7028697, DOI: 10.3389/fonc.2020.00118.
- Zammataro L, Lopez S, Bellone S, Pettinella F, Bonazzoli E, Perrone E, Zhao S, Menderes G, Altwerger G, Han C, Zeybek B, Bianchi A, Manzano A, Manara P, Cocco E, Buza N, Hui P, Wong S, Ravaggi A, Bignotti E, Romani C, Todeschini P, Zanotti L, Odicino F, Pecorelli S, Donzelli C, Ardighieri L, Angioli R, Raspagliesi F, Scambia G, Choi J, Dong W, Bilguvar K, Alexandrov LB, Silasi DA, Huang GS, Ratner E, Azodi M, Schwartz PE, Pirazzoli V, Stiegler AL, Boggon TJ, Lifton RP, Schlessinger J, Santin AD. Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy. Proceedings Of The National Academy Of Sciences Of The United States Of America 2019, 116: 22730-22736. PMID: 31624127, PMCID: PMC6842590, DOI: 10.1073/pnas.1911385116.
- Chai H, Grommisch B, DiAdamo A, Wen J, Hui P, Li P. Inverted duplication, triplication and quintuplication through sequential breakage-fusion-bridge events induced by a terminal deletion at 5p in a case of spontaneous abortion. Molecular Genetics & Genomic Medicine 2019, 7: e00965. PMID: 31478360, PMCID: PMC6785443, DOI: 10.1002/mgg3.965.
- Buza N, Baine I, Hui P. Precision genotyping diagnosis of lung tumors with trophoblastic morphology in young women. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2019, 32: 1271-1280. PMID: 31028360, DOI: 10.1038/s41379-019-0275-z.
- Kaulen LD, Galluzzo D, Hui P, Barbiero F, Karschnia P, Huttner A, Fulbright R, Baehring JM. Prognostic markers for immunodeficiency-associated primary central nervous system lymphoma. Journal Of Neuro-oncology 2019, 144: 107-115. PMID: 31190317, DOI: 10.1007/s11060-019-03208-w.
- Buza N, McGregor SM, Barroilhet L, Zheng X, Hui P. Paternal uniparental isodisomy of tyrosine hydroxylase locus at chromosome 11p15.4: spectrum of phenotypical presentations simulating hydatidiform moles. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2019, 32: 1180-1188. PMID: 30952972, DOI: 10.1038/s41379-019-0266-0.
- Wu X, Snir O, Rottmann D, Wong S, Buza N, Hui P. Minimal microsatellite shift in microsatellite instability high endometrial cancer: a significant pitfall in diagnostic interpretation. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2019, 32: 650-658. PMID: 30443012, DOI: 10.1038/s41379-018-0179-3.
- Deshmukh U, Black J, Perez-Irizarry J, Passarelli R, Levy K, Rostkowski A, Hui P, Rutherford TJ, Santin AD, Azodi M, Silasi DA, Ratner E, Litkouhi B, Schwartz PE. Adjuvant Hormonal Therapy for Low-Grade Endometrial Stromal Sarcoma. Reproductive Sciences (Thousand Oaks, Calif.) 2019, 26: 600-608. PMID: 29843577, DOI: 10.1177/1933719118778801.
- Celli R, Hui P, Triscott H, Bogardus S, Gibson J, Hwang M, Robert ME. Clinical Insignficance of Monoclonal T-Cell Populations and Duodenal Intraepithelial T-Cell Phenotypes in Celiac and Nonceliac Patients. The American Journal Of Surgical Pathology 2019, 43: 151-160. PMID: 30334829, DOI: 10.1097/PAS.0000000000001172.
- Baine I, Hui P. Practical applications of DNA genotyping in diagnostic pathology. Expert Review Of Molecular Diagnostics 2019, 19: 175-188. PMID: 30638393, DOI: 10.1080/14737159.2019.1568874.
- Li C, Bonazzoli E, Bellone S, Choi J, Dong W, Menderes G, Altwerger G, Han C, Manzano A, Bianchi A, Pettinella F, Manara P, Lopez S, Yadav G, Riccio F, Zammataro L, Zeybek B, Yang-Hartwich Y, Buza N, Hui P, Wong S, Ravaggi A, Bignotti E, Romani C, Todeschini P, Zanotti L, Zizioli V, Odicino F, Pecorelli S, Ardighieri L, Silasi DA, Litkouhi B, Ratner E, Azodi M, Huang GS, Schwartz PE, Lifton RP, Schlessinger J, Santin AD. Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors. Proceedings Of The National Academy Of Sciences Of The United States Of America 2019, 116: 619-624. PMID: 30584090, PMCID: PMC6329978, DOI: 10.1073/pnas.1814027116.
- Feinberg J, Albright B, Black J, Lu L, Passarelli R, Gysler S, Whicker M, Altwerger G, Menderes G, Hui P, Santin AD, Azodi M, Silasi DA, Ratner ES, Litkouhi B, Schwartz PE. Ten-Year Comparison Study of Type 1 and 2 Endometrial Cancers: Risk Factors and Outcomes. Gynecologic And Obstetric Investigation 2019, 84: 290-297. PMID: 30602164, DOI: 10.1159/000493132.
- Hui P. Gestational Trophoblastic Tumors: A Timely Review of Diagnostic Pathology. Archives Of Pathology & Laboratory Medicine 2019, 143: 65-74. PMID: 30407075, DOI: 10.5858/arpa.2018-0234-RA.
- Cho KR, Cooper K, Croce S, Djordevic B, Herrington S, Howitt B, Hui P, Ip P, Koebel M, Lax S, Quade BJ, Shaw P, Vidal A, Yemelyanova A, Clarke B, Hedrick Ellenson L, Longacre TA, Shih IM, McCluggage WG, Malpica A, Oliva E, Parkash V, Matias-Guiu X. International Society of Gynecological Pathologists (ISGyP) Endometrial Cancer Project: Guidelines From the Special Techniques and Ancillary Studies Group. International Journal Of Gynecological Pathology : Official Journal Of The International Society Of Gynecological Pathologists 2019, 38 Suppl 1: S114-S122. PMID: 29521846, PMCID: PMC6296838, DOI: 10.1097/PGP.0000000000000496.
- Hui P, Zhang L. Frontiers in Gynecologic Pathology. Archives Of Pathology & Laboratory Medicine 2018, 142: 1457-1458. PMID: 30500276, DOI: 10.5858/arpa.2018-0360-ED.
- Liu Y, Blakely M, Sigel K, Thin TH, Hui P, Donovan M, Gaisa MM. Biomarker P16 predicts progression risk of anal low-grade squamous intraepithelial lesions. AIDS (London, England) 2018, 32: 2309-2316. PMID: 30005024, PMCID: PMC6862769, DOI: 10.1097/QAD.0000000000001957.
- Bonazzoli E, Predolini F, Cocco E, Bellone S, Altwerger G, Menderes G, Zammataro L, Bianchi A, Pettinella F, Riccio F, Han C, Yadav G, Lopez S, Manzano A, Manara P, Buza N, Hui P, Wong S, Litkouhi B, Ratner E, Silasi DA, Huang GS, Azodi M, Schwartz PE, Schlessinger J, Santin AD. Inhibition of BET Bromodomain Proteins with GS-5829 and GS-626510 in Uterine Serous Carcinoma, a Biologically Aggressive Variant of Endometrial Cancer. Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research 2018, 24: 4845-4853. PMID: 29941483, PMCID: PMC6168417, DOI: 10.1158/1078-0432.CCR-18-0864.
- Fader AN, Roque DM, Siegel E, Buza N, Hui P, Abdelghany O, Chambers SK, Secord AA, Havrilesky L, O'Malley DM, Backes F, Nevadunsky N, Edraki B, Pikaart D, Lowery W, ElSahwi KS, Celano P, Bellone S, Azodi M, Litkouhi B, Ratner E, Silasi DA, Schwartz PE, Santin AD. Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu. Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology 2018, 36: 2044-2051. PMID: 29584549, DOI: 10.1200/JCO.2017.76.5966.
- Buza N, Wong S, Hui P. FOXL2 Mutation Analysis of Ovarian Sex Cord-Stromal Tumors: Genotype-Phenotype Correlation With Diagnostic Considerations. International Journal Of Gynecological Pathology : Official Journal Of The International Society Of Gynecological Pathologists 2018, 37: 305-315. PMID: 28700438, DOI: 10.1097/PGP.0000000000000426.
- Yoder N, Marks A, Hui P, Litkouhi B, Cron J. Low-Grade Astrocytoma within a Mature Cystic Teratoma in an Adolescent Patient. Journal Of Pediatric And Adolescent Gynecology 2018, 31: 325-327. PMID: 29107097, DOI: 10.1016/j.jpag.2017.10.005.
- Hui P, Gysler SM, Uduman M, Togun TA, Prado DE, Brambs CE, Nallur S, Schwartz PE, Rutherford TJ, Santin AD, Weidhaas JB, Ratner ES. MicroRNA signatures discriminate between uterine and ovarian serous carcinomas. Human Pathology 2018, 76: 133-140. PMID: 29518404, DOI: 10.1016/j.humpath.2018.02.019.
- McCluggage WG, Judge MJ, Alvarado-Cabrero I, Duggan MA, Horn LC, Hui P, Ordi J, Otis CN, Park KJ, Plante M, Stewart CJR, Wiredu EK, Rous B, Hirschowitz L. Data Set for the Reporting of Carcinomas of the Cervix: Recommendations From the International Collaboration on Cancer Reporting (ICCR). International Journal Of Gynecological Pathology : Official Journal Of The International Society Of Gynecological Pathologists 2018, 37: 205-228. PMID: 28700433, DOI: 10.1097/PGP.0000000000000412.
- Altwerger G, Bonazzoli E, Bellone S, Egawa-Takata T, Menderes G, Pettinella F, Bianchi A, Riccio F, Feinberg J, Zammataro L, Han C, Yadav G, Dugan K, Morneault A, Ponte JF, Buza N, Hui P, Wong S, Litkouhi B, Ratner E, Silasi DA, Huang GS, Azodi M, Schwartz PE, Santin AD. In Vitro and In Vivo Activity of IMGN853, an Antibody-Drug Conjugate Targeting Folate Receptor Alpha Linked to DM4, in Biologically Aggressive Endometrial Cancers. Molecular Cancer Therapeutics 2018, 17: 1003-1011. PMID: 29440294, PMCID: PMC5932245, DOI: 10.1158/1535-7163.MCT-17-0930.
- Zuo T, Wong S, Buza N, Hui P. KRAS mutation of extraovarian implants of serous borderline tumor: prognostic indicator for adverse clinical outcome. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2018, 31: 350-357. PMID: 29027536, DOI: 10.1038/modpathol.2017.121.
- Albright BB, Black JD, Passarelli R, Gysler S, Whicker M, Altwerger G, Menderes G, Buza N, Hui P, Santin AD, Azodi M, Silasi DA, Ratner ES, Litkouhi B, Schwartz PE. Associated characteristics and impact on recurrence and survival of free-floating tumor fragments in the lumen of fallopian tubes in Type I and Type II endometrial cancer. Gynecologic Oncology Reports 2018, 23: 28-33. PMID: 29387776, PMCID: PMC5771964, DOI: 10.1016/j.gore.2018.01.003.
- Boto AN, Hui P. Hormone producing gynecological tumors: pathologic entities and clinical significance. Expert Review Of Endocrinology & Metabolism 2018, 13: 9-24. PMID: 30063444, DOI: 10.1080/17446651.2018.1411799.
- Menderes G, Bonazzoli E, Bellone S, Black J, Predolini F, Pettinella F, Masserdotti A, Zammataro L, Altwerger G, Buza N, Hui P, Wong S, Litkouhi B, Ratner E, Silasi DA, Azodi M, Schwartz PE, Santin AD. SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody-Drug Conjugate, Shows Antitumor Activity in Uterine and Ovarian Carcinosarcoma with HER2/Neu Expression. Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research 2017, 23: 5836-5845. PMID: 28679774, PMCID: PMC5626613, DOI: 10.1158/1078-0432.CCR-16-2862.
- Snir OL, DeJoseph M, Wong S, Buza N, Hui P. Frequent homozygosity in both mature and immature ovarian teratomas: a shared genetic basis of tumorigenesis. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2017, 30: 1467-1475. PMID: 28664933, DOI: 10.1038/modpathol.2017.66.
- Menderes G, Bonazzoli E, Bellone S, Altwerger G, Black JD, Dugan K, Pettinella F, Masserdotti A, Riccio F, Bianchi A, Zammataro L, de Haydu C, Buza N, Hui P, Wong S, Huang GS, Litkouhi B, Ratner E, Silasi DA, Azodi M, Schwartz PE, Santin AD. Superior in vitro and in vivo activity of trastuzumab-emtansine (T-DM1) in comparison to trastuzumab, pertuzumab and their combination in epithelial ovarian carcinoma with high HER2/neu expression. Gynecologic Oncology 2017, 147: 145-152. PMID: 28705408, PMCID: PMC5605415, DOI: 10.1016/j.ygyno.2017.07.009.
- Buza N, Hui P. Immunohistochemistry in Gynecologic Pathology: An Example-Based Practical Update. Archives Of Pathology & Laboratory Medicine 2017, 141: 1052-1071. PMID: 28745567, DOI: 10.5858/arpa.2016-0541-RA.
- Menderes G, Bonazzoli E, Bellone S, Black J, Altwerger G, Masserdotti A, Pettinella F, Zammataro L, Buza N, Hui P, Wong S, Litkouhi B, Ratner E, Silasi DA, Huang GS, Azodi M, Schwartz PE, Santin AD. SYD985, a novel duocarmycin-based HER2-targeting antibody-drug conjugate, shows promising antitumor activity in epithelial ovarian carcinoma with HER2/Neu expression. Gynecologic Oncology 2017, 146: 179-186. PMID: 28473206, PMCID: PMC5533304, DOI: 10.1016/j.ygyno.2017.04.023.
- Hardee S, Prasad ML, Hui P, Dinauer CA, Morotti RA. Pathologic Characteristics, Natural History, and Prognostic Implications of BRAFV600E Mutation in Pediatric Papillary Thyroid Carcinoma. Pediatric And Developmental Pathology : The Official Journal Of The Society For Pediatric Pathology And The Paediatric Pathology Society 2017, 20: 206-212. PMID: 28521635, DOI: 10.1177/1093526616689628.
- Deshmukh U, McAdow M, Black J, Hui P, Azodi M. Isolated port site recurrence of node-negative clinical stage IB1 cervical adenocarcinoma. Gynecologic Oncology Reports 2017, 20: 54-57. PMID: 28331901, PMCID: PMC5348602, DOI: 10.1016/j.gore.2017.03.001.
- Wong S, Hong W, Hui P, Buza N. Comprehensive Analysis of PAX8 Expression in Epithelial Malignancies of the Uterine Cervix. International Journal Of Gynecological Pathology : Official Journal Of The International Society Of Gynecological Pathologists 2017, 36: 101-106. PMID: 27362905, DOI: 10.1097/PGP.0000000000000309.
- Hui P, Buza N, Murphy KM, Ronnett BM. Hydatidiform Moles: Genetic Basis and Precision Diagnosis. Annual Review Of Pathology 2017, 12: 449-485. PMID: 28135560, DOI: 10.1146/annurev-pathol-052016-100237.
- Bellone S, Bignotti E, Lonardi S, Ferrari F, Centritto F, Masserdotti A, Pettinella F, Black J, Menderes G, Altwerger G, Hui P, Lopez S, de Haydu C, Bonazzoli E, Predolini F, Zammataro L, Cocco E, Ferrari F, Ravaggi A, Romani C, Facchetti F, Sartori E, Odicino FE, Silasi DA, Litkouhi B, Ratner E, Azodi M, Schwartz PE, Santin AD. Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro. Gynecologic Oncology 2017, 144: 146-152. PMID: 27894751, PMCID: PMC5183545, DOI: 10.1016/j.ygyno.2016.11.023.
- Zhao S, Bellone S, Lopez S, Thakral D, Schwab C, English DP, Black J, Cocco E, Choi J, Zammataro L, Predolini F, Bonazzoli E, Bi M, Buza N, Hui P, Wong S, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Odicino F, Pecorelli S, Donzelli C, Ardighieri L, Facchetti F, Falchetti M, Silasi DA, Ratner E, Azodi M, Schwartz PE, Mane S, Angioli R, Terranova C, Quick CM, Edraki B, Bilgüvar K, Lee M, Choi M, Stiegler AL, Boggon TJ, Schlessinger J, Lifton RP, Santin AD. Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition. Proceedings Of The National Academy Of Sciences Of The United States Of America 2016, 113: 12238-12243. PMID: 27791010, PMCID: PMC5087050, DOI: 10.1073/pnas.1614120113.
- Snir OL, Buza N, Hui P. Mucinous epithelial tumours arising from ovarian mature teratomas: a tissue genotyping study. Histopathology 2016, 69: 383-92. PMID: 26952875, DOI: 10.1111/his.12959.
- Black J, Menderes G, Bellone S, Schwab CL, Bonazzoli E, Ferrari F, Predolini F, De Haydu C, Cocco E, Buza N, Hui P, Wong S, Lopez S, Ratner E, Silasi DA, Azodi M, Litkouhi B, Schwartz PE, Goedings P, Beusker PH, van der Lee MM, Timmers CM, Dokter WH, Santin AD. SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody-Drug Conjugate, Shows Antitumor Activity in Uterine Serous Carcinoma with HER2/Neu Expression. Molecular Cancer Therapeutics 2016, 15: 1900-9. PMID: 27256376, DOI: 10.1158/1535-7163.MCT-16-0163.
- Cocco E, Lopez S, Black J, Bellone S, Bonazzoli E, Predolini F, Ferrari F, Schwab CL, Menderes G, Zammataro L, Buza N, Hui P, Wong S, Zhao S, Bai Y, Rimm DL, Ratner E, Litkouhi B, Silasi DA, Azodi M, Schwartz PE, Santin AD. Dual CCNE1/PIK3CA targeting is synergistic in CCNE1-amplified/PIK3CA-mutated uterine serous carcinomas in vitro and in vivo. British Journal Of Cancer 2016, 115: 303-11. PMID: 27351214, PMCID: PMC4973158, DOI: 10.1038/bjc.2016.198.
- Levi AW, Bernstein JI, Hui P, Duch K, Schofield K, Chhieng DC. A Comparison of the Roche Cobas HPV Test With the Hybrid Capture 2 Test for the Detection of High-Risk Human Papillomavirus Genotypes. Archives Of Pathology & Laboratory Medicine 2016, 140: 153-7. PMID: 26910220, DOI: 10.5858/arpa.2015-0027-OA.
- Buza N, Ziai J, Hui P. Mismatch repair deficiency testing in clinical practice. Expert Review Of Molecular Diagnostics 2016, 16: 591-604. PMID: 26895074, DOI: 10.1586/14737159.2016.1156533.
- Alomari AK, Glusac EJ, Choi J, Hui P, Seeley EH, Caprioli RM, Watsky KL, Urban J, Lazova R. Congenital nevi versus metastatic melanoma in a newborn to a mother with malignant melanoma - diagnosis supported by sex chromosome analysis and Imaging Mass Spectrometry. Journal Of Cutaneous Pathology 2015, 42: 757-64. PMID: 25989266, DOI: 10.1111/cup.12523.
- Arleo EK, Schwartz PE, Hui P, McCarthy S. Review of Leiomyoma Variants. AJR. American Journal Of Roentgenology 2015, 205: 912-21. PMID: 26397344, DOI: 10.2214/AJR.14.13946.
- Munday WR, Hui P. Heterozygous bone marrow in a homozygous mature ovarian teratoma: a challenge to the germ cell theory or incidental somatic heterotopia? Journal Of Clinical Pathology 2015, 68: 666-9. PMID: 25979987, DOI: 10.1136/jclinpath-2015-202959.
- Ezaldein H, Lott JP, McNiff JM, Hui P, Buza N, Ko CJ. Grading of atypia in genital skin lesions: routine microscopic evaluation and use of p16 immunostaining. Journal Of Cutaneous Pathology 2015, 42: 519-26. PMID: 25951050, DOI: 10.1111/cup.12525.
- Hong W, Abi-Raad R, Alomari AK, Hui P, Buza N. Diagnostic application of KRAS mutation testing in uterine microglandular proliferations. Human Pathology 2015, 46: 1000-5. PMID: 25997988, DOI: 10.1016/j.humpath.2015.03.010.
- Cai G, Bernstein J, Aslanian HR, Hui P, Chhieng D. Endoscopic ultrasound-guided fine-needle aspiration biopsy of autoimmune pancreatitis: diagnostic clues and pitfalls. Journal Of The American Society Of Cytopathology 2015, 4: 211-217. PMID: 31051756, DOI: 10.1016/j.jasc.2015.01.006.
- Perincheri S, Hui P. KRAS mutation testing in clinical practice. Expert Review Of Molecular Diagnostics 2015, 15: 375-84. PMID: 25487540, DOI: 10.1586/14737159.2015.986102.
- Alomari AK, Kelley BJ, Damisah E, Marks A, Hui P, DiLuna M, Vortmeyer A. Craniopharyngioma arising in a Rathke's cleft cyst: case report. Journal Of Neurosurgery. Pediatrics 2015, 15: 250-4. PMID: 25555112, DOI: 10.3171/2014.11.PEDS14370.
- Carr RJ, Hui P, Buza N. Intravenous leiomyomatosis revisited: an experience of 14 cases at a single medical center. International Journal Of Gynecological Pathology : Official Journal Of The International Society Of Gynecological Pathologists 2015, 34: 169-76. PMID: 25675187, DOI: 10.1097/PGP.0000000000000127.
- Zheng X, Wu B, Buza N, Hui P. [Ancillary techniques in refining the diagnosis of hydatidiform mole]. Zhonghua Bing Li Xue Za Zhi Chinese Journal Of Pathology 2015, 44: 15-20. PMID: 25765025.
- Nicoletti R, Lopez S, Bellone S, Cocco E, Schwab CL, Black JD, Centritto F, Zhu L, Bonazzoli E, Buza N, Hui P, Mezzanzanica D, Canevari S, Schwartz PE, Rutherford TJ, Santin AD. T-DM1, a novel antibody-drug conjugate, is highly effective against uterine and ovarian carcinosarcomas overexpressing HER2. Clinical & Experimental Metastasis 2015, 32: 29-38. PMID: 25398397, PMCID: PMC4310789, DOI: 10.1007/s10585-014-9688-8.
- Adeniran AJ, Hui P. Best practice of BRAF V600E mutation testing for the diagnosis and management of thyroid cancers. Expert Review Of Endocrinology & Metabolism 2014, 9: 571-577. PMID: 30736195, DOI: 10.1586/17446651.2014.951635.
- English DP, Bellone S, Schwab CL, Bortolomai I, Bonazzoli E, Cocco E, Buza N, Hui P, Lopez S, Ratner E, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Santin AD. T-DM1, a novel antibody-drug conjugate, is highly effective against primary HER2 overexpressing uterine serous carcinoma in vitro and in vivo. Cancer Medicine 2014, 3: 1256-65. PMID: 24890382, PMCID: PMC4302675, DOI: 10.1002/cam4.274.
- Buza N, Xu F, Wu W, Carr RJ, Li P, Hui P. Recurrent chromosomal aberrations in intravenous leiomyomatosis of the uterus: high-resolution array comparative genomic hybridization study. Human Pathology 2014, 45: 1885-92. PMID: 25033729, DOI: 10.1016/j.humpath.2014.05.010.
- Buza N, Hui P. Egg donor pregnancy: a potential pitfall in DNA genotyping diagnosis of hydatidiform moles. International Journal Of Gynecological Pathology : Official Journal Of The International Society Of Gynecological Pathologists 2014, 33: 507-10. PMID: 25083967, DOI: 10.1097/PGP.0b013e3182a1028b.
- Ahmad AK, Hui P, Litkouhi B, Azodi M, Rutherford T, McCarthy S, Xu ML, Schwartz PE, Ratner E. Institutional review of primary non-hodgkin lymphoma of the female genital tract: a 33-year experience. International Journal Of Gynecological Cancer : Official Journal Of The International Gynecological Cancer Society 2014, 24: 1250-5. PMID: 25010039, PMCID: PMC8139417, DOI: 10.1097/IGC.0000000000000201.
- Abi-Raad R, Alomari A, Hui P, Buza N. Mitotically active microglandular hyperplasia of the cervix: a case series with implications for the differential diagnosis. International Journal Of Gynecological Pathology : Official Journal Of The International Society Of Gynecological Pathologists 2014, 33: 524-30. PMID: 25083971, DOI: 10.1097/PGP.0000000000000086.
- Alomari A, Abi-Raad R, Buza N, Hui P. Frequent KRAS mutation in complex mucinous epithelial lesions of the endometrium. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2014, 27: 675-80. PMID: 24186144, DOI: 10.1038/modpathol.2013.186.
- Buza N, Hui P. Immunohistochemistry and other ancillary techniques in the diagnosis of gestational trophoblastic diseases. Seminars In Diagnostic Pathology 2014, 31: 223-32. PMID: 24907943, DOI: 10.1053/j.semdp.2014.03.004.
- Schwartz PE, Hui P, McCarthy S. Hormonal therapy for aggressive angiomyxoma: a case report and proposed management algorithm. Journal Of Lower Genital Tract Disease 2014, 18: E55-61. PMID: 24402356, DOI: 10.1097/LGT.0b013e3182a22019.
- Much M, Buza N, Hui P. Tissue identity testing of cancer by short tandem repeat polymorphism: pitfalls of interpretation in the presence of microsatellite instability. Human Pathology 2014, 45: 549-55. PMID: 24444463, DOI: 10.1016/j.humpath.2013.10.022.
- Schalper KA, Kumar S, Hui P, Rimm DL, Gershkovich P. A retrospective population-based comparison of HER2 immunohistochemistry and fluorescence in situ hybridization in breast carcinomas: impact of 2007 American Society of Clinical Oncology/College of American Pathologists criteria. Archives Of Pathology & Laboratory Medicine 2014, 138: 213-9. PMID: 24164555, DOI: 10.5858/arpa.2012-0617-OA.
- Hui P. Next generation sequencing: chemistry, technology and applications. Topics In Current Chemistry 2014, 336: 1-18. PMID: 22648865, DOI: 10.1007/128_2012_329.
- Buza N, Rutherford T, Hui P. Genotyping diagnosis of nongestational choriocarcinoma involving fallopian tube and broad ligament: a case study. International Journal Of Gynecological Pathology : Official Journal Of The International Society Of Gynecological Pathologists 2014, 33: 58-63. PMID: 24300537, DOI: 10.1097/PGP.0b013e31827cd386.
- Zheng XZ, Hui P, Chang B, Gao ZB, Li Y, Wu BQ, Zhang B. STR DNA genotyping of hydatidiform moles in South China. International Journal Of Clinical And Experimental Pathology 2014, 7: 4704-19. PMID: 25197342, PMCID: PMC4152032.
- Bernstein J, Virk RK, Hui P, Prasad A, Westra WH, Tallini G, Adeniran AJ, Udelsman R, Sasaki CT, Roman SA, Sosa JA, Prasad ML. Tall cell variant of papillary thyroid microcarcinoma: clinicopathologic features with BRAF(V600E) mutational analysis. Thyroid : Official Journal Of The American Thyroid Association 2013, 23: 1525-31. PMID: 23682579, DOI: 10.1089/thy.2013.0154.
- Orsaria M, Khelifa S, Buza N, Kamath A, Hui P. Chromosome 17 polysomy: correlation with histological parameters and HER2NEU gene amplification. Journal Of Clinical Pathology 2013, 66: 1070-5. PMID: 23908451, DOI: 10.1136/jclinpath-2013-201506.
- Buza N, Hui P. Marked heterogeneity of HER2/NEU gene amplification in endometrial serous carcinoma. Genes, Chromosomes & Cancer 2013, 52: 1178-86. PMID: 24123408, DOI: 10.1002/gcc.22113.
- Buza N, English DP, Santin AD, Hui P. Toward standard HER2 testing of endometrial serous carcinoma: 4-year experience at a large academic center and recommendations for clinical practice. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2013, 26: 1605-12. PMID: 23765245, DOI: 10.1038/modpathol.2013.113.
- Cai G, Wong R, Chhieng D, Levy GH, Gettinger SN, Herbst RS, Puchalski JT, Homer RJ, Hui P. Identification of EGFR mutation, KRAS mutation, and ALK gene rearrangement in cytological specimens of primary and metastatic lung adenocarcinoma. Cancer Cytopathology 2013, 121: 500-7. PMID: 23495083, DOI: 10.1002/cncy.21288.
- Bossuyt V, Buza N, Ngo NT, Much MA, Asis MC, Schwartz PE, Hui P. Cancerous 'floater': a lesson learned about tissue identity testing, endometrial cancer and microsatellite instability. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2013, 26: 1264-9. PMID: 23558568, DOI: 10.1038/modpathol.2013.63.
- Gunal A, Hui P, Kilic S, Xu R, Jain D, Mitchell K, Robert M, Kenney B. KRAS mutations are associated with specific morphologic features in colon cancer. Journal Of Clinical Gastroenterology 2013, 47: 509-14. PMID: 23090042, DOI: 10.1097/MCG.0b013e3182703030.
- Alomari A, Hui P, Xu M. Composite peripheral T-cell lymphoma not otherwise specified, and B-cell small lymphocytic lymphoma presenting with hemophagocytic lymphohistiocytosis. International Journal Of Surgical Pathology 2013, 21: 303-8. PMID: 23129836, DOI: 10.1177/1066896912464047.
- Bao F, Chen GR, Hui P, Cai GP. [Diagnosis, histopathologic grading and prognostic moleculer marker analysis in patients with pancreatic neuroendocrine neoplasm]. Zhonghua Bing Li Xue Za Zhi Chinese Journal Of Pathology 2013, 42: 426-32. PMID: 24060085, DOI: 10.3760/cma.j.issn.0529-5807.2013.06.016.
- Buza N, Hui P. Partial hydatidiform mole: histologic parameters in correlation with DNA genotyping. International Journal Of Gynecological Pathology : Official Journal Of The International Society Of Gynecological Pathologists 2013, 32: 307-15. PMID: 23518914, DOI: 10.1097/PGP.0b013e3182626011.
- Liu M, Mor G, Cheng H, Xiang X, Hui P, Rutherford T, Yin G, Rimm DL, Holmberg J, Alvero A, Silasi DA. High frequency of putative ovarian cancer stem cells with CD44/CK19 coexpression is associated with decreased progression-free intervals in patients with recurrent epithelial ovarian cancer. Reproductive Sciences (Thousand Oaks, Calif.) 2013, 20: 605-15. PMID: 23171677, PMCID: PMC3635069, DOI: 10.1177/1933719112461183.
- Zhong H, Liu Y, Talmor M, Wu B, Hui P. Deparaffinization and lysis by hydrothermal pressure (pressure cooking) coupled with chaotropic salt column purification: a rapid and efficient method of DNA extraction from formalin-fixed paraffin-embedded tissue. Diagnostic Molecular Pathology : The American Journal Of Surgical Pathology, Part B 2013, 22: 52-8. PMID: 23370427, DOI: 10.1097/PDM.0b013e318263f092.
- Zhao S, Choi M, Overton JD, Bellone S, Roque DM, Cocco E, Guzzo F, English DP, Varughese J, Gasparrini S, Bortolomai I, Buza N, Hui P, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Carrara L, Pecorelli S, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Stiegler AL, Mane S, Boggon TJ, Schlessinger J, Lifton RP, Santin AD. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Proceedings Of The National Academy Of Sciences Of The United States Of America 2013, 110: 2916-21. PMID: 23359684, PMCID: PMC3581983, DOI: 10.1073/pnas.1222577110.
- Liu Y, Wu BQ, Zhong HH, Hui P, Fang WG. Screening for EGFR and KRAS mutations in non-small cell lung carcinomas using DNA extraction by hydrothermal pressure coupled with PCR-based direct sequencing. International Journal Of Clinical And Experimental Pathology 2013, 6: 1880-9. PMID: 24040454, PMCID: PMC3759496.
- Virk RK, Van Dyke AL, Finkelstein A, Prasad A, Gibson J, Hui P, Theoharis CG, Carling T, Roman SA, Sosa JA, Udelsman R, Prasad ML. BRAFV600E mutation in papillary thyroid microcarcinoma: a genotype-phenotype correlation. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2013, 26: 62-70. PMID: 22918165, DOI: 10.1038/modpathol.2012.152.
- Waldron-Lynch F, Inzucchi SE, Menard L, Tai N, Preston-Hurlburt P, Hui P, McClaskey J, Hagopian WA, Meffre E, Marks PW, Wen L, Herold KC. Relapsing and remitting severe hypoglycemia due to a monoclonal anti-insulin antibody heralding a case of multiple myeloma. The Journal Of Clinical Endocrinology And Metabolism 2012, 97: 4317-23. PMID: 23074233, PMCID: PMC3513536, DOI: 10.1210/jc.2012-2388.
- Hui P, Liu Y. [Genetic basis of molar pregnancy]. Zhonghua Bing Li Xue Za Zhi Chinese Journal Of Pathology 2012, 41: 721-4. PMID: 23302329, DOI: 10.3760/cma.j.issn.0529-5807.2012.11.001.
- Oktay MH, Hui P. Molecular pathology as the driving force for personalized oncology. Expert Review Of Molecular Diagnostics 2012, 12: 811-3. PMID: 23249199, DOI: 10.1586/erm.12.121.
- Cai G, Mahooti S, Lipata FM, Chhieng D, Hui P. Diagnostic value of K-ras mutation analysis for pancreaticobiliary cytology specimens with indeterminate diagnosis. Cancer Cytopathology 2012, 120: 313-8. PMID: 22367918, DOI: 10.1002/cncy.21188.
- Levi AW, Beckman D, Hui P, Schofield K, Harigopal M, Chhieng DC. Comparing two methods of detection for Chlamydia trachomatis in liquid-based Papanicolaou tests. American Journal Of Clinical Pathology 2012, 138: 236-40. PMID: 22904135, DOI: 10.1309/AJCP2B7XQTCNAMJP.
- Finkelstein A, Levy GH, Hui P, Prasad A, Virk R, Chhieng DC, Carling T, Roman SA, Sosa JA, Udelsman R, Theoharis CG, Prasad ML. Papillary thyroid carcinomas with and without BRAF V600E mutations are morphologically distinct. Histopathology 2012, 60: 1052-9. PMID: 22335197, DOI: 10.1111/j.1365-2559.2011.04149.x.
- Guzzo F, Bellone S, Buza N, Hui P, Carrara L, Varughese J, Cocco E, Betti M, Todeschini P, Gasparrini S, Schwartz PE, Rutherford TJ, Angioli R, Pecorelli S, Santin AD. HER2/neu as a potential target for immunotherapy in gynecologic carcinosarcomas. International Journal Of Gynecological Pathology : Official Journal Of The International Society Of Gynecological Pathologists 2012, 31: 211-21. PMID: 22498937, PMCID: PMC3366047, DOI: 10.1097/PGP.0b013e31823bb24d.
- Ziai J, Hui P. BRAF mutation testing in clinical practice. Expert Review Of Molecular Diagnostics 2012, 12: 127-38. PMID: 22369373, DOI: 10.1586/erm.12.1.
- Todeschini P, Cocco E, Bellone S, Varughese J, Lin K, Carrara L, Guzzo F, Buza N, Hui P, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD. Her2/neu extracellular domain shedding in uterine serous carcinoma: implications for immunotherapy with trastuzumab. British Journal Of Cancer 2011, 105: 1176-82. PMID: 21915118, PMCID: PMC3208497, DOI: 10.1038/bjc.2011.369.
- Levi AW, Harigopal M, Hui P, Schofield K, Chhieng DC. Use of high-risk human papillomavirus testing in patients with low-grade squamous intraepithelial lesions. Cancer Cytopathology 2011, 119: 228-34. PMID: 21732551, DOI: 10.1002/cncy.20172.
- Adeniran AJ, Theoharis C, Hui P, Prasad ML, Hammers L, Carling T, Udelsman R, Chhieng DC. Reflex BRAF testing in thyroid fine-needle aspiration biopsy with equivocal and positive interpretation: a prospective study. Thyroid : Official Journal Of The American Thyroid Association 2011, 21: 717-23. PMID: 21568726, DOI: 10.1089/thy.2011.0021.
- Levi AW, Harigopal M, Hui P, Schofield K, Chhieng DC. Comparison of Affirm VPIII and Papanicolaou tests in the detection of infectious vaginitis. American Journal Of Clinical Pathology 2011, 135: 442-7. PMID: 21350100, DOI: 10.1309/AJCP7TBN5VZUGLZU.
- Varughese J, Hui P, Lu L, Yu H, Schwartz PE. Clear cell cancer of the uterine corpus: the association of clinicopathologic parameters and treatment on disease progression. Journal Of Oncology 2011, 2011: 628084. PMID: 22187554, PMCID: PMC3236522, DOI: 10.1155/2011/628084.
- Steffensen KD, Alvero AB, Yang Y, Waldstrøm M, Hui P, Holmberg JC, Silasi DA, Jakobsen A, Rutherford T, Mor G. Prevalence of epithelial ovarian cancer stem cells correlates with recurrence in early-stage ovarian cancer. Journal Of Oncology 2011, 2011: 620523. PMID: 21904548, PMCID: PMC3166719, DOI: 10.1155/2011/620523.
- Adeniran AJ, Hui P, Chhieng DC, Prasad ML, Schofield K, Theoharis C. BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance. Acta Cytologica 2011, 55: 570-5. PMID: 22156468, DOI: 10.1159/000333274.
- Liu CR, Hui P. [Molecular diagnosis of molar pregnancy]. Zhonghua Bing Li Xue Za Zhi Chinese Journal Of Pathology 2011, 40: 6-10. PMID: 21429351.
- Hui P. Molecular diagnosis of gestational trophoblastic disease. Expert Review Of Molecular Diagnostics 2010, 10: 1023-34. PMID: 21080819, DOI: 10.1586/erm.10.93.
- Ou-Yang RJ, Hui P, Yang XJ, Zynger DL. Expression of glypican 3 in placental site trophoblastic tumor. Diagnostic Pathology 2010, 5: 64. PMID: 20868507, PMCID: PMC2954974, DOI: 10.1186/1746-1596-5-64.
- Ratner ES, Tuck D, Richter C, Nallur S, Patel RM, Schultz V, Hui P, Schwartz PE, Rutherford TJ, Weidhaas JB. MicroRNA signatures differentiate uterine cancer tumor subtypes. Gynecologic Oncology 2010, 118: 251-7. PMID: 20542546, PMCID: PMC2918705, DOI: 10.1016/j.ygyno.2010.05.010.
- Ratner E, Lu L, Boeke M, Barnett R, Nallur S, Chin LJ, Pelletier C, Blitzblau R, Tassi R, Paranjape T, Hui P, Godwin AK, Yu H, Risch H, Rutherford T, Schwartz P, Santin A, Matloff E, Zelterman D, Slack FJ, Weidhaas JB. A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk. Cancer Research 2010, 70: 6509-15. PMID: 20647319, PMCID: PMC2923587, DOI: 10.1158/0008-5472.CAN-10-0689.
- Siddon A, Hui P. Glial heterotopia of the uterine cervix: DNA genotyping confirmation of its fetal origin. International Journal Of Gynecological Pathology : Official Journal Of The International Society Of Gynecological Pathologists 2010, 29: 394-7. PMID: 20567155, DOI: 10.1097/PGP.0b013e3181c5a7e8.
- Richter CE, Hui P, Buza N, Silasi DA, Azodi M, Santin AD, Schwartz PE, Rutherford TJ. HER-2/NEU overexpression in vulvar Paget disease: the Yale experience. Journal Of Clinical Pathology 2010, 63: 544-7. PMID: 20418225, DOI: 10.1136/jcp.2010.077446.
- Lipata F, Parkash V, Talmor M, Bell S, Chen S, Maric V, Hui P. Precise DNA genotyping diagnosis of hydatidiform mole. Obstetrics And Gynecology 2010, 115: 784-794. PMID: 20308840, DOI: 10.1097/AOG.0b013e3181d489ec.
- El-Sahwi K, Bellone S, Cocco E, Cargnelutti M, Casagrande F, Bellone M, Abu-Khalaf M, Buza N, Tavassoli FA, Hui P, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD. In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma. British Journal Of Cancer 2010, 102: 134-43. PMID: 19920829, PMCID: PMC2813756, DOI: 10.1038/sj.bjc.6605448.
- El-Sahwi K, Bellone S, Cocco E, Casagrande F, Bellone M, Abu-Khalaf M, Buza N, Tavassoli FA, Hui P, Rüttinger D, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD. Overexpression of EpCAM in uterine serous papillary carcinoma: implications for EpCAM-specific immunotherapy with human monoclonal antibody adecatumumab (MT201). Molecular Cancer Therapeutics 2010, 9: 57-66. PMID: 20053761, PMCID: PMC2806489, DOI: 10.1158/1535-7163.MCT-09-0675.
- Yan Z, Hui P. Minimal uterine serous carcinoma with extrauterine tumor of identical morphology: an immunohistochemical study of 13 cases. Applied Immunohistochemistry & Molecular Morphology : AIMM / Official Publication Of The Society For Applied Immunohistochemistry 2010, 18: 75-9. PMID: 19956063, DOI: 10.1097/PAI.0b013e3181b1d10e.
- Xu M, Schwartz P, Rutherford T, Azodi M, Santin A, Silasi D, Martel M, Hui P. HER-2/neu receptor gene status in endometrial carcinomas: a tissue microarray study. Histopathology 2010, 56: 269-73. PMID: 20102407, DOI: 10.1111/j.1365-2559.2009.03464.x.
- Baehring J, Hui P, Piepmeier J, Bannykh SI. Anaplastic oligoastrocytoma in Turcot syndrome. Journal Of Neuro-oncology 2009, 95: 293-298. PMID: 19495563, DOI: 10.1007/s11060-009-9928-y.
- Mac MT, Chung F, Lin F, Hui P, Balzer BL, Wang HL. Expression of hepatocyte antigen in small intestinal epithelium and adenocarcinoma. American Journal Of Clinical Pathology 2009, 132: 80-5. PMID: 19864237, DOI: 10.1309/AJCPUD0P5NQBOYPK.
- Xu ML, Yang B, Carcangiu ML, Hui P. Epithelioid trophoblastic tumor: comparative genomic hybridization and diagnostic DNA genotyping. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2009, 22: 232-8. PMID: 18820674, DOI: 10.1038/modpathol.2008.165.
- Galan A, Hui P, McNiff JM. Absence of human herpesvirus 8 in pemphigus and bullous pemphigoid. International Journal Of Clinical And Experimental Pathology 2009, 2: 456-62. PMID: 19294004, PMCID: PMC2655157.
- Xu Y, Dotto J, Hui Y, Lawton K, Schofield K, Hui P. High grade cervical intraepithelial neoplasia and viral load of high-risk human papillomavirus: significant correlations in patients of 22 years old or younger. International Journal Of Clinical And Experimental Pathology 2009, 2: 169-75. PMID: 19079652, PMCID: PMC2583634.
- Dotto J, Hui P. Lack of genetic association between exaggerated placental site reaction and placental site trophoblastic tumor. International Journal Of Gynecological Pathology : Official Journal Of The International Society Of Gynecological Pathologists 2008, 27: 562-7. PMID: 18753963, DOI: 10.1097/PGP.0b013e31816d1d00.
- He H, Luthringer DJ, Hui P, Lau SK, Weiss LM, Chu PG. Expression of CD56 and WT1 in ovarian stroma and ovarian stromal tumors. The American Journal Of Surgical Pathology 2008, 32: 884-90. PMID: 18425046, DOI: 10.1097/PAS.0b013e3181609d59.
- Bifulco C, Johnson C, Hao L, Kermalli H, Bell S, Hui P. Genotypic analysis of hydatidiform mole: an accurate and practical method of diagnosis. The American Journal Of Surgical Pathology 2008, 32: 445-51. PMID: 18300805, DOI: 10.1097/PAS.0b013e3181520034.
- De Stefano D, Li P, Xiang B, Hui P, Zambrano E. Pulmonary atresia with intact ventricular septum (PA-IVS) in monozygotic twins. American Journal Of Medical Genetics. Part A 2008, 146A: 525-8. PMID: 18203206, DOI: 10.1002/ajmg.a.32160.
- Makhlouf HR, Ahrens W, Agarwal B, Dow N, Marshalleck JJ, Lee EL, Dotto JE, Hui P, Sobin LH, Oliveira A, Miettinen M. Synovial sarcoma of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 10 cases. The American Journal Of Surgical Pathology 2008, 32: 275-81. PMID: 18223331, DOI: 10.1097/PAS.0b013e31812e6a58.
- Dotto J, Mezzetti T, Hui P. Primary or secondary? Genotyping confirmation of an ovarian primary carcinoid tumor. International Journal Of Gynecological Pathology : Official Journal Of The International Society Of Gynecological Pathologists 2008, 27: 33-6. PMID: 18156971, DOI: 10.1097/pgp.0b13e318053df4.
- Baehring JM, Landry ML, Cooper D, Hui P, Bannykh S. CSF IgH gene rearrangement analysis in isolated post-transplant lymphoproliferative disorder of the central nervous system. Journal Of Neuro-oncology 2008, 86: 57-60. PMID: 17909942, DOI: 10.1007/s11060-007-9429-9.
- Zhang MQ, Lin F, Hui P, Chen ZM, Ritter JH, Wang HL. Expression of mucins, SIMA, villin, and CDX2 in small-intestinal adenocarcinoma. American Journal Of Clinical Pathology 2007, 128: 808-16. PMID: 17951204, DOI: 10.1309/JAF3KVGJHQCJ1QF9.
- Hui P, Wang HL, Chu P, Yang B, Huang J, Baergen RN, Sklar J, Yang XJ, Soslow RA. Absence of Y chromosome in human placental site trophoblastic tumor. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2007, 20: 1055-60. PMID: 17643092, DOI: 10.1038/modpathol.3800941.
- Hui P. [Pathogenesis of endometrial cancer: clinicopathologic implications]. Zhonghua Bing Li Xue Za Zhi Chinese Journal Of Pathology 2006, 35: 705-7. PMID: 17374250.
- Patton KT, Cheng L, Papavero V, Blum MG, Yeldandi AV, Adley BP, Luan C, Diaz LK, Hui P, Yang XJ. Benign metastasizing leiomyoma: clonality, telomere length and clinicopathologic analysis. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2006, 19: 130-40. PMID: 16357844, DOI: 10.1038/modpathol.3800504.
- Fadare O, Parkash V, Carcangiu ML, Hui P. Epithelioid trophoblastic tumor: clinicopathological features with an emphasis on uterine cervical involvement. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2006, 19: 75-82. PMID: 16258513, DOI: 10.1038/modpathol.3800485.
- Xing M, Westra WH, Tufano RP, Cohen Y, Rosenbaum E, Rhoden KJ, Carson KA, Vasko V, Larin A, Tallini G, Tolaney S, Holt EH, Hui P, Umbricht CB, Basaria S, Ewertz M, Tufaro AP, Califano JA, Ringel MD, Zeiger MA, Sidransky D, Ladenson PW. BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. The Journal Of Clinical Endocrinology And Metabolism 2005, 90: 6373-9. PMID: 16174717, DOI: 10.1210/jc.2005-0987.
- Hui P, Fedoriw G. Recurrent endometrial stromal tumors with smooth-muscle differentiation and a protracted clinical course. Nature Clinical Practice. Oncology 2005, 2: 588-93, quiz. PMID: 16270099, DOI: 10.1038/ncponc0340.
- Hui P, Li N, Johnson C, De Wever I, Sciot R, Manfioletti G, Tallini G. HMGA proteins in malignant peripheral nerve sheath tumor and synovial sarcoma: preferential expression of HMGA2 in malignant peripheral nerve sheath tumor. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2005, 18: 1519-26. PMID: 16056249, DOI: 10.1038/modpathol.3800464.
- Yatsula B, Lin S, Read AJ, Poholek A, Yates K, Yue D, Hui P, Perkins AS. Identification of binding sites of EVI1 in mammalian cells. The Journal Of Biological Chemistry 2005, 280: 30712-22. PMID: 16006653, DOI: 10.1074/jbc.M504293200.
- Kelly MG, O'malley DM, Hui P, McAlpine J, Yu H, Rutherford TJ, Azodi M, Schwartz PE. Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy. Gynecologic Oncology 2005, 98: 353-9. PMID: 16005947, DOI: 10.1016/j.ygyno.2005.06.012.
- Fadare O, Parkash V, Yilmaz Y, Mariappan MR, Ma L, Hileeto D, Qumsiyeh MB, Hui P. Correction: Perivascular epithelioid cell tumor (PEComa) of the uterine cervix associated with intraabdominal "PEComatosis": A clinicopathological study with comparative genomic hybridization analysis. World Journal Of Surgical Oncology 2005, 3: 25. PMID: 15869711, PMCID: PMC1097764, DOI: 10.1186/1477-7819-3-25.
- Hui P, Martel M, Parkash V. Gestational trophoblastic diseases: recent advances in histopathologic diagnosis and related genetic aspects. Advances In Anatomic Pathology 2005, 12: 116-25. PMID: 15900112, DOI: 10.1097/01.pap.0000163960.11107.73.
- Ma L, Kowalski D, Javed K, Hui P. Atypical angiomyolipoma of kidney in a patient with tuberous sclerosis: a case report with p53 gene mutation analysis. Archives Of Pathology & Laboratory Medicine 2005, 129: 676-9. PMID: 15859641, DOI: 10.5858/2005-129-0676-AAOKIA.
- Hui P, Kelly M, O'Malley DM, Tavassoli F, Schwartz PE. Minimal uterine serous carcinoma: a clinicopathological study of 40 cases. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2005, 18: 75-82. PMID: 15389257, DOI: 10.1038/modpathol.3800271.
- Kelly MG, O'Malley D, Hui P, McAlpine J, Dziura J, Rutherford TJ, Azodi M, Chambers SK, Schwartz PE. Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation. Gynecologic Oncology 2004, 95: 469-73. PMID: 15581948, DOI: 10.1016/j.ygyno.2004.08.030.
- Fadare O, Parkash V, Yilmaz Y, Mariappan MR, Ma L, Hileeto D, Qumsiyeh MB, Hui P. Perivascular epithelioid cell tumor (PEComa) of the uterine cervix associated with intraabdominal "PEComatosis": A clinicopathological study with comparative genomic hybridization analysis. World Journal Of Surgical Oncology 2004, 2: 35. PMID: 15494070, PMCID: PMC527874, DOI: 10.1186/1477-7819-2-35.
- Bhattacharjee P, Hui P, McNiff J. Human herpesvirus-8 is not associated with angiolymphoid hyperplasia with eosinophilia. Journal Of Cutaneous Pathology 2004, 31: 612-5. PMID: 15330993, DOI: 10.1111/j.0303-6987.2004.00240.x.
- Li N, McNiff J, Hui P, Manfioletti G, Tallini G. Differential expression of HMGA1 and HMGA2 in dermatofibroma and dermatofibrosarcoma protuberans: potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity. The American Journal Of Dermatopathology 2004, 26: 267-72. PMID: 15249855, DOI: 10.1097/00000372-200408000-00001.
- Zhang SS, Wei J, Qin H, Zhang L, Xie B, Hui P, Deisseroth A, Barnstable CJ, Fu XY. STAT3-mediated signaling in the determination of rod photoreceptor cell fate in mouse retina. Investigative Ophthalmology & Visual Science 2004, 45: 2407-12. PMID: 15223824, DOI: 10.1167/iovs.04-0003.
- Hui P, Riba A, Pejovic T, Johnson T, Baergen RN, Ward D. Comparative genomic hybridization study of placental site trophoblastic tumour: a report of four cases. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2004, 17: 248-51. PMID: 14657956, DOI: 10.1038/modpathol.3800025.
- Hui P, Howe JG, Crouch J, Nimmakayalu M, Qumsiyeh MB, Tallini G, Flynn SD, Smith BR. Real-time quantitative RT-PCR of cyclin D1 mRNA in mantle cell lymphoma: comparison with FISH and immunohistochemistry. Leukemia & Lymphoma 2003, 44: 1385-94. PMID: 12952233, DOI: 10.1080/1042819031000079168.
- Hui P, Glusac EJ, Sinard JH, Perkins AS. Clonal analysis of cutaneous fibrous histiocytoma (dermatofibroma). Journal Of Cutaneous Pathology 2002, 29: 385-9. PMID: 12139632, DOI: 10.1034/j.1600-0560.2002.290701.x.
- Fusco A, Chiappetta G, Hui P, Garcia-Rostan G, Golden L, Kinder BK, Dillon DA, Giuliano A, Cirafici AM, Santoro M, Rosai J, Tallini G. Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer. The American Journal Of Pathology 2002, 160: 2157-67. PMID: 12057919, PMCID: PMC1850819, DOI: 10.1016/S0002-9440(10)61164-9.
- Tang LH, Hui P, Garcia-Tsao G, Salem RR, Jain D. Multiple angiomyolipomata of the liver: a case report. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2002, 15: 167-71. PMID: 11850546, DOI: 10.1038/modpathol.3880509.
- Zambrano E, Marshalko SJ, Jaffe CC, Hui P. Isolated noncompaction of the ventricular myocardium: clinical and molecular aspects of a rare cardiomyopathy. Laboratory Investigation; A Journal Of Technical Methods And Pathology 2002, 82: 117-22. PMID: 11850525, DOI: 10.1038/labinvest.3780404.
- Hui P, Perkins A, Glusac E. Assessment of clonality in melanocytic nevi. Journal Of Cutaneous Pathology 2001, 28: 140-4. PMID: 11168766.
- Hui P, Parkash V, Perkins AS, Carcangiu ML. Pathogenesis of placental site trophoblastic tumor may require the presence of a paternally derived X chromosome. Laboratory Investigation; A Journal Of Technical Methods And Pathology 2000, 80: 965-72. PMID: 10879746, DOI: 10.1038/labinvest.3780099.
Biography
Pei Hui, MD, PhD, is a pathologist who specializes in gynecological diseases and cancers, including endometrial, ovarian, and fallopian tube cancers.
“You understand disease better through pathology,” Dr. Hui says. “You learn how it develops and its mechanisms at a cellular and molecular level.”
Dr. Hui points out that although pathologists rarely see patients face-to-face, they are still in charge of the well-being of the patient through the microscopic diagnosis. “We look at 30 to 50 cases each day, so in a way you could say that we see more patients than any other physician,” he says.
Dr. Hui says that he enjoys working as a team to provide better care for patients. For example, on any given day, he might be talking via phone, email, or text, to a patient’s oncologist or doctor. “We are informative for them because we provide timely and accurate diagnosis and using new biomarkers that may change the patient treatment options. The boundary between physician and pathologist is smaller than ever.”
What most excites Dr. Hui is the ability to improve diagnostic accuracy and find new biomarkers to guide clinical management for patients and prognosis. He continues his research in that area as professor and director of gynecologic pathology at Yale School of Medicine.
Titles
- Professor of Pathology and of Obstetrics, Gynecology and Reproductive Sciences
- Director, Gynecologic Pathology
- Clinical Director, Molecular Diagnostics Laboratories
Education & Training
- FellowshipMemorial Sloan Kettering Cancer Center (2001)
- ResidencyYale School of Medicine (2000)
- PhDSUNY at Buffalo (1994)
- MSPeking University, Tumor Biology (1987)
- MDXian Medical University (1984)
Languages Spoken
- 官話 / 官话 (Chinese-Mandarin)
- English
Additional Information
- F. Stephen Vogel Award: United States and Canadian Academy of Pathology (2001)
- AB of Pathology, Molecular Genetic Pathology (2003)
- AB of Pathology, Anatomic & Clinical Pathology (2000)
- Stendahl K, Gilani SM, Basturk O, Hui P, Sigel C, Cai G. Intraductal papillary neoplasm of the bile duct: Cytomorphologic and molecular features. Cancer Cytopathology 2022 PMID: 36041224, DOI: 10.1002/cncy.22637.
- Yadav G, Roque DM, Bellone S, Manavella DD, Hartwich TMP, Zipponi M, Harold J, Tymon-Rosario J, Mutlu L, Altwerger G, Menderes G, Ratner E, Buza N, Hui P, Huang GS, Andikyan V, Clark M, Azodi M, Schwartz PE, Alexandrov LB, Santin AD. Synergistic activity of neratinib in combination with olaparib in uterine serous carcinoma overexpressing HER2/neu. Gynecologic Oncology 2022, 166: 351-357. PMID: 35641325, DOI: 10.1016/j.ygyno.2022.05.021.
- Sun T, Zuo T, Hui P, Cai G. Significance of KRAS mutation testing in biliary brushing cytology specimens: A 10-year retrospective review. Cancer Cytopathology 2022, 130: 558-565. PMID: 35417072, DOI: 10.1002/cncy.22579.
- Moriarty K, Yu M, Hussain N, Zgutka K, Sanders MM, Harigopal M, Wang J, Wang X, Hui P, Liu C, Sink D, Shields A. COVID-19 & differential effects in twins: Insights from Placenta Pathology. Placenta 2022, 124: 62-66. PMID: 35640456, PMCID: PMC9121647, DOI: 10.1016/j.placenta.2022.05.014.
- Buza N, Hui P. Characteristics of HER2 Gene Amplification by Fluorescence In Situ Hybridization in Endometrial Serous Carcinoma. Archives Of Pathology & Laboratory Medicine 2022, 146: 0. PMID: 35687792, DOI: 10.5858/arpa.2021-0547-OA.
- Beroukhim G, Ozgediz D, Cohen PJ, Hui P, Morotti R, Schwartz PE, Yang-Hartwich Y, Vash-Margita A. Progression of Cystadenoma to Mucinous Borderline Ovarian Tumor in Young Females: Case Series and Literature Review. Journal Of Pediatric And Adolescent Gynecology 2022, 35: 359-367. PMID: 34843973, DOI: 10.1016/j.jpag.2021.11.003.
- Roque DM, Siegel ER, Buza N, Bellone S, Silasi DA, Huang GS, Andikyan V, Clark M, Azodi M, Schwartz PE, Rao GG, Reader JC, Hui P, Tymon-Rosario JR, Harold J, Mauricio D, Zeybek B, Menderes G, Altwerger G, Ratner E, Santin AD. Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer. British Journal Of Cancer 2022, 126: 1695-1703. PMID: 35149854, PMCID: PMC8853032, DOI: 10.1038/s41416-022-01717-6.
- Petrone ME, Rothman JE, Breban MI, Ott IM, Russell A, Lasek-Nesselquist E, Badr H, Kelly K, Omerza G, Renzette N, Watkins AE, Kalinich CC, Alpert T, Brito AF, Earnest R, Tikhonova IR, Castaldi C, Kelly JP, Shudt M, Plitnick J, Schneider E, Murphy S, Neal C, Laszlo E, Altajar A, Pearson C, Muyombwe A, Downing R, Razeq J, Niccolai L, Wilson MS, Anderson ML, Wang J, Liu C, Hui P, Mane S, Taylor BP, Hanage WP, Landry ML, Peaper DR, Bilguvar K, Fauver JR, Vogels CBF, Gardner LM, Pitzer VE, St George K, Adams MD, Grubaugh ND. Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 variants Alpha and Iota. Communications Biology 2022, 5: 439. PMID: 35545661, PMCID: PMC9095641, DOI: 10.1038/s42003-022-03347-3.
- Hui P. Endometrial Polyp in Postmenopausal Women. Archives Of Pathology & Laboratory Medicine 2022 PMID: 35512230, DOI: 10.5858/arpa.2021-0557-RA.
- DeFina SM, Wang J, Yang L, Zhou H, Adams J, Cushing W, Tuohy B, Hui P, Liu C, Pham K. SaliVISION: a rapid saliva-based COVID-19 screening and diagnostic test with high sensitivity and specificity. Scientific Reports 2022, 12: 5729. PMID: 35388102, PMCID: PMC8986854, DOI: 10.1038/s41598-022-09718-4.
- Bellone S, Roque DM, Siegel ER, Buza N, Hui P, Bonazzoli E, Guglielmi A, Zammataro L, Nagarkatti N, Zaidi S, Lee J, Silasi DA, Huang GS, Andikyan V, Damast S, Clark M, Azodi M, Schwartz PE, Tymon-Rosario JR, Harold JA, Mauricio D, Zeybek B, Menderes G, Altwerger G, Ratner E, Alexandrov LB, Iwasaki A, Kong Y, Song E, Dong W, Elvin JA, Choi J, Santin AD. A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability. Cancer 2022, 128: 1206-1218. PMID: 34875107, DOI: 10.1002/cncr.34025.
- Li JY, Mutlu L, Tymon-Rosario J, Khadraoui W, Nagarkatti N, Hui P, Buza N, Lu L, Schwartz P, Menderes G. Clinicopathologic characteristics and oncologic outcomes in adenosarcoma of gynecologic sites. Gynecologic Oncology Reports 2022, 39: 100913. PMID: 35005157, PMCID: PMC8715286, DOI: 10.1016/j.gore.2021.100913.
- Pawlica P, Yario TA, White S, Wang J, Moss WN, Hui P, Vinetz JM, Steitz JA. SARS-CoV-2 expresses a microRNA-like small RNA able to selectively repress host genes. Proceedings Of The National Academy Of Sciences Of The United States Of America 2021, 118 PMID: 34903581, PMCID: PMC8719879, DOI: 10.1073/pnas.2116668118.
- Assem H, Rottmann D, Finkelstein A, Wang M, Ratner E, Santin AD, Buza N, Hui P. Minimal uterine serous carcinoma and endometrial polyp: a close clinicopathological relationship. Human Pathology 2021, 118: 1-8. PMID: 34508766, DOI: 10.1016/j.humpath.2021.09.001.
- Tymon-Rosario J, Bonazzoli E, Bellone S, Manzano A, Pelligra S, Guglielmi A, Gnutti B, Nagarkatti N, Zeybek B, Manara P, Zammataro L, Harold J, Mauricio D, Buza N, Hui P, Altwerger G, Menderes G, Ratner E, Clark M, Andikyan V, Huang GS, Silasi DA, Azodi M, Schwartz PE, Santin AD. DHES0815A, a novel antibody-drug conjugate targeting HER2/neu, is highly active against uterine serous carcinomas in vitro and in vivo. Gynecologic Oncology 2021, 163: 334-341. PMID: 34452746, PMCID: PMC8722447, DOI: 10.1016/j.ygyno.2021.08.014.
- Wang M, Hui P. A Timely Update of Immunohistochemistry and Molecular Classification in the Diagnosis and Risk Assessment of Endometrial Carcinomas. Archives Of Pathology & Laboratory Medicine 2021, 145: 1367-1378. PMID: 34673912, DOI: 10.5858/arpa.2021-0098-RA.
- Mackow NA, Abi-Raad R, Kerantzas CA, Hui P, Malinis M, Azar MM. Increased Detection of Mycobacterium tuberculosis Disease Using a Tissue-Based Laboratory-Developed Polymerase Chain Reaction Assay Compared to Standard Diagnostics. The American Journal Of Tropical Medicine And Hygiene 2021, 105: 1657-1661. PMID: 34544041, PMCID: PMC8641361, DOI: 10.4269/ajtmh.21-0104.
- Rottmann D, Assem H, Matsumoto N, Wong S, Hui P, Buza N. Does Specimen Type Have an Impact on HER2 Status in Endometrial Serous Carcinoma? Discordant HER2 Status of Paired Endometrial Biopsy and Hysterectomy Specimens in the Presence of Frequent Intratumoral Heterogeneity. International Journal Of Gynecological Pathology : Official Journal Of The International Society Of Gynecological Pathologists 2021, 40: 263-271. PMID: 32897955, DOI: 10.1097/PGP.0000000000000690.
- Tal R, Lawal T, Granger E, Simoni M, Hui P, Buza N, Pal L. Genital tuberculosis screening at an academic fertility center in the United States. American Journal Of Obstetrics And Gynecology 2020, 223: 737.e1-737.e10. PMID: 32497612, DOI: 10.1016/j.ajog.2020.05.045.
- Snir OL, DeJoseph M, Wu X, Rottmann D, Wong S, Buza N, Hui P. Lack of genetic homozygosity in prepubertal teratomas: divergent pathogenesis distinct from that of teratomas in adolescents. Laboratory Investigation; A Journal Of Technical Methods And Pathology 2020, 100: 1447-1454. PMID: 32694569, DOI: 10.1038/s41374-020-0468-6.
- Zheng XZ, Qin XY, Chen SW, Wang P, Zhan Y, Zhong PP, Buza N, Jin YL, Wu BQ, Hui P. Heterozygous/dispermic complete mole confers a significantly higher risk for post-molar gestational trophoblastic disease. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2020, 33: 1979-1988. PMID: 32404958, DOI: 10.1038/s41379-020-0566-4.
- Ordulu Z, Chai H, Peng G, McDonald AG, De Nictolis M, Garcia-Fernandez E, Hardisson D, Prat J, Li P, Hui P, Oliva E, Buza N. Molecular and clinicopathologic characterization of intravenous leiomyomatosis. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2020, 33: 1844-1860. PMID: 32341498, PMCID: PMC7483566, DOI: 10.1038/s41379-020-0546-8.
- Hui P. Germline NLRP7 mutations: genomic imprinting and hydatidiform mole. Virchows Archiv : An International Journal Of Pathology 2020, 477: 175-176. PMID: 32577811, DOI: 10.1007/s00428-020-02802-y.
- Fader AN, Roque DM, Siegel E, Buza N, Hui P, Abdelghany O, Chambers S, Secord AA, Havrilesky L, O'Malley DM, Backes FJ, Nevadunsky N, Edraki B, Pikaart D, Lowery W, ElSahwi K, Celano P, Bellone S, Azodi M, Litkouhi B, Ratner E, Silasi DA, Schwartz PE, Santin AD. Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis. Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research 2020, 26: 3928-3935. PMID: 32601075, PMCID: PMC8792803, DOI: 10.1158/1078-0432.CCR-20-0953.
- Wong S, Hui P, Buza N. Frequent loss of mutation-specific mismatch repair protein expression in nonneoplastic endometrium of Lynch syndrome patients. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2020, 33: 1172-1181. PMID: 31932681, DOI: 10.1038/s41379-020-0455-x.
- Simpson S, Simoni M, Hui P, Taylor H, Buza N. Extragonadal Yolk Sac Tumor Limited to the Myometrium: Report of a Case With Potential Fertility Preservation and Molecular Analysis Suggesting Germ Cell Origin. International Journal Of Gynecological Pathology : Official Journal Of The International Society Of Gynecological Pathologists 2020, 39: 247-253. PMID: 31033797, DOI: 10.1097/PGP.0000000000000601.
- Pelligra S, Buza N, Hui P, Bellone S, Zeybek B, Ratner E, Schwartz PE, Scambia G, Santin AD. Selection of HER2/NEU negative tumor cells as a mechanism of resistance to trastuzumab in uterine serous carcinoma. Gynecologic Oncology Reports 2020, 32: 100554. PMID: 32140533, PMCID: PMC7049633, DOI: 10.1016/j.gore.2020.100554.
- Chen PH, Hui P, Buza N. Bilateral Signet-ring Stromal Tumor of the Ovary: A Case Report With Next-generation Sequencing Analysis and FOXL2 Mutation Testing. International Journal Of Gynecological Pathology : Official Journal Of The International Society Of Gynecological Pathologists 2020, 39: 193-198. PMID: 30676431, DOI: 10.1097/PGP.0000000000000579.
- Perrone E, Manara P, Lopez S, Bellone S, Bonazzoli E, Manzano A, Zammataro L, Bianchi A, Zeybek B, Buza N, Tymon-Rosario J, Altwerger G, Han C, Menderes G, Huang GS, Ratner E, Silasi DA, Azodi M, Hui P, Schwartz PE, Scambia G, Santin AD. Sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2, shows cytotoxic activity against poorly differentiated endometrial adenocarcinomas in vitro and in vivo. Molecular Oncology 2020, 14: 645-656. PMID: 31891442, PMCID: PMC7053235, DOI: 10.1002/1878-0261.12627.
- Lopez S, Perrone E, Bellone S, Bonazzoli E, Zeybek B, Han C, Tymon-Rosario J, Altwerger G, Menderes G, Bianchi A, Zammataro L, Manzano A, Manara P, Ratner E, Silasi DA, Huang GS, Azodi M, Schwartz PE, Raspagliesi F, Angioli R, Buza N, Hui P, Bond HM, Santin AD. Preclinical activity of sacituzumab govitecan (IMMU-132) in uterine and ovarian carcinosarcomas. Oncotarget 2020, 11: 560-570. PMID: 32082489, PMCID: PMC7007291, DOI: 10.18632/oncotarget.27342.
- Han C, Perrone E, Zeybek B, Bellone S, Tymon-Rosario J, Altwerger G, Menderes G, Feinberg J, Haines K, Muller Karger ME, Bianchi A, Zammataro L, Manzano A, Bonazzoli E, Manara P, Buza N, Hui P, Ratner E, Silasi DA, Huang GS, Azodi M, Schwartz PE, Lopez S, Santin AD. In vitro and in vivo activity of sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (Trop-2) in uterine serous carcinoma. Gynecologic Oncology 2020, 156: 430-438. PMID: 31839338, DOI: 10.1016/j.ygyno.2019.11.018.
- Zeybek B, Manzano A, Bianchi A, Bonazzoli E, Bellone S, Buza N, Hui P, Lopez S, Perrone E, Manara P, Zammataro L, Altwerger G, Han C, Tymon-Rosario J, Menderes G, Ratner E, Silasi DA, Huang GS, Azodi M, Schwartz PE, Santin A. Cervical carcinomas that overexpress human trophoblast cell-surface marker (Trop-2) are highly sensitive to the antibody-drug conjugate sacituzumab govitecan. Scientific Reports 2020, 10: 973. PMID: 31969666, PMCID: PMC6976591, DOI: 10.1038/s41598-020-58009-3.
- Rottmann D, Snir OL, Wu X, Wong S, Hui P, Santin AD, Buza N. HER2 testing of gynecologic carcinosarcomas: tumor stratification for potential targeted therapy. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2020, 33: 118-127. PMID: 31477811, DOI: 10.1038/s41379-019-0358-x.
- Perrone E, Lopez S, Zeybek B, Bellone S, Bonazzoli E, Pelligra S, Zammataro L, Manzano A, Manara P, Bianchi A, Buza N, Tymon-Rosario J, Altwerger G, Han C, Menderes G, Ratner E, Silasi DA, Azodi M, Hui P, Schwartz PE, Scambia G, Santin AD. Preclinical Activity of Sacituzumab Govitecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) Linked to the Active Metabolite of Irinotecan (SN-38), in Ovarian Cancer. Frontiers In Oncology 2020, 10: 118. PMID: 32117765, PMCID: PMC7028697, DOI: 10.3389/fonc.2020.00118.
- Zammataro L, Lopez S, Bellone S, Pettinella F, Bonazzoli E, Perrone E, Zhao S, Menderes G, Altwerger G, Han C, Zeybek B, Bianchi A, Manzano A, Manara P, Cocco E, Buza N, Hui P, Wong S, Ravaggi A, Bignotti E, Romani C, Todeschini P, Zanotti L, Odicino F, Pecorelli S, Donzelli C, Ardighieri L, Angioli R, Raspagliesi F, Scambia G, Choi J, Dong W, Bilguvar K, Alexandrov LB, Silasi DA, Huang GS, Ratner E, Azodi M, Schwartz PE, Pirazzoli V, Stiegler AL, Boggon TJ, Lifton RP, Schlessinger J, Santin AD. Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy. Proceedings Of The National Academy Of Sciences Of The United States Of America 2019, 116: 22730-22736. PMID: 31624127, PMCID: PMC6842590, DOI: 10.1073/pnas.1911385116.
- Chai H, Grommisch B, DiAdamo A, Wen J, Hui P, Li P. Inverted duplication, triplication and quintuplication through sequential breakage-fusion-bridge events induced by a terminal deletion at 5p in a case of spontaneous abortion. Molecular Genetics & Genomic Medicine 2019, 7: e00965. PMID: 31478360, PMCID: PMC6785443, DOI: 10.1002/mgg3.965.
- Buza N, Baine I, Hui P. Precision genotyping diagnosis of lung tumors with trophoblastic morphology in young women. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2019, 32: 1271-1280. PMID: 31028360, DOI: 10.1038/s41379-019-0275-z.
- Kaulen LD, Galluzzo D, Hui P, Barbiero F, Karschnia P, Huttner A, Fulbright R, Baehring JM. Prognostic markers for immunodeficiency-associated primary central nervous system lymphoma. Journal Of Neuro-oncology 2019, 144: 107-115. PMID: 31190317, DOI: 10.1007/s11060-019-03208-w.
- Buza N, McGregor SM, Barroilhet L, Zheng X, Hui P. Paternal uniparental isodisomy of tyrosine hydroxylase locus at chromosome 11p15.4: spectrum of phenotypical presentations simulating hydatidiform moles. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2019, 32: 1180-1188. PMID: 30952972, DOI: 10.1038/s41379-019-0266-0.
- Wu X, Snir O, Rottmann D, Wong S, Buza N, Hui P. Minimal microsatellite shift in microsatellite instability high endometrial cancer: a significant pitfall in diagnostic interpretation. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2019, 32: 650-658. PMID: 30443012, DOI: 10.1038/s41379-018-0179-3.
- Deshmukh U, Black J, Perez-Irizarry J, Passarelli R, Levy K, Rostkowski A, Hui P, Rutherford TJ, Santin AD, Azodi M, Silasi DA, Ratner E, Litkouhi B, Schwartz PE. Adjuvant Hormonal Therapy for Low-Grade Endometrial Stromal Sarcoma. Reproductive Sciences (Thousand Oaks, Calif.) 2019, 26: 600-608. PMID: 29843577, DOI: 10.1177/1933719118778801.
- Celli R, Hui P, Triscott H, Bogardus S, Gibson J, Hwang M, Robert ME. Clinical Insignficance of Monoclonal T-Cell Populations and Duodenal Intraepithelial T-Cell Phenotypes in Celiac and Nonceliac Patients. The American Journal Of Surgical Pathology 2019, 43: 151-160. PMID: 30334829, DOI: 10.1097/PAS.0000000000001172.
- Baine I, Hui P. Practical applications of DNA genotyping in diagnostic pathology. Expert Review Of Molecular Diagnostics 2019, 19: 175-188. PMID: 30638393, DOI: 10.1080/14737159.2019.1568874.
- Li C, Bonazzoli E, Bellone S, Choi J, Dong W, Menderes G, Altwerger G, Han C, Manzano A, Bianchi A, Pettinella F, Manara P, Lopez S, Yadav G, Riccio F, Zammataro L, Zeybek B, Yang-Hartwich Y, Buza N, Hui P, Wong S, Ravaggi A, Bignotti E, Romani C, Todeschini P, Zanotti L, Zizioli V, Odicino F, Pecorelli S, Ardighieri L, Silasi DA, Litkouhi B, Ratner E, Azodi M, Huang GS, Schwartz PE, Lifton RP, Schlessinger J, Santin AD. Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors. Proceedings Of The National Academy Of Sciences Of The United States Of America 2019, 116: 619-624. PMID: 30584090, PMCID: PMC6329978, DOI: 10.1073/pnas.1814027116.
- Feinberg J, Albright B, Black J, Lu L, Passarelli R, Gysler S, Whicker M, Altwerger G, Menderes G, Hui P, Santin AD, Azodi M, Silasi DA, Ratner ES, Litkouhi B, Schwartz PE. Ten-Year Comparison Study of Type 1 and 2 Endometrial Cancers: Risk Factors and Outcomes. Gynecologic And Obstetric Investigation 2019, 84: 290-297. PMID: 30602164, DOI: 10.1159/000493132.
- Hui P. Gestational Trophoblastic Tumors: A Timely Review of Diagnostic Pathology. Archives Of Pathology & Laboratory Medicine 2019, 143: 65-74. PMID: 30407075, DOI: 10.5858/arpa.2018-0234-RA.
- Cho KR, Cooper K, Croce S, Djordevic B, Herrington S, Howitt B, Hui P, Ip P, Koebel M, Lax S, Quade BJ, Shaw P, Vidal A, Yemelyanova A, Clarke B, Hedrick Ellenson L, Longacre TA, Shih IM, McCluggage WG, Malpica A, Oliva E, Parkash V, Matias-Guiu X. International Society of Gynecological Pathologists (ISGyP) Endometrial Cancer Project: Guidelines From the Special Techniques and Ancillary Studies Group. International Journal Of Gynecological Pathology : Official Journal Of The International Society Of Gynecological Pathologists 2019, 38 Suppl 1: S114-S122. PMID: 29521846, PMCID: PMC6296838, DOI: 10.1097/PGP.0000000000000496.
- Hui P, Zhang L. Frontiers in Gynecologic Pathology. Archives Of Pathology & Laboratory Medicine 2018, 142: 1457-1458. PMID: 30500276, DOI: 10.5858/arpa.2018-0360-ED.
- Liu Y, Blakely M, Sigel K, Thin TH, Hui P, Donovan M, Gaisa MM. Biomarker P16 predicts progression risk of anal low-grade squamous intraepithelial lesions. AIDS (London, England) 2018, 32: 2309-2316. PMID: 30005024, PMCID: PMC6862769, DOI: 10.1097/QAD.0000000000001957.
- Bonazzoli E, Predolini F, Cocco E, Bellone S, Altwerger G, Menderes G, Zammataro L, Bianchi A, Pettinella F, Riccio F, Han C, Yadav G, Lopez S, Manzano A, Manara P, Buza N, Hui P, Wong S, Litkouhi B, Ratner E, Silasi DA, Huang GS, Azodi M, Schwartz PE, Schlessinger J, Santin AD. Inhibition of BET Bromodomain Proteins with GS-5829 and GS-626510 in Uterine Serous Carcinoma, a Biologically Aggressive Variant of Endometrial Cancer. Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research 2018, 24: 4845-4853. PMID: 29941483, PMCID: PMC6168417, DOI: 10.1158/1078-0432.CCR-18-0864.
- Fader AN, Roque DM, Siegel E, Buza N, Hui P, Abdelghany O, Chambers SK, Secord AA, Havrilesky L, O'Malley DM, Backes F, Nevadunsky N, Edraki B, Pikaart D, Lowery W, ElSahwi KS, Celano P, Bellone S, Azodi M, Litkouhi B, Ratner E, Silasi DA, Schwartz PE, Santin AD. Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu. Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology 2018, 36: 2044-2051. PMID: 29584549, DOI: 10.1200/JCO.2017.76.5966.
- Buza N, Wong S, Hui P. FOXL2 Mutation Analysis of Ovarian Sex Cord-Stromal Tumors: Genotype-Phenotype Correlation With Diagnostic Considerations. International Journal Of Gynecological Pathology : Official Journal Of The International Society Of Gynecological Pathologists 2018, 37: 305-315. PMID: 28700438, DOI: 10.1097/PGP.0000000000000426.
- Yoder N, Marks A, Hui P, Litkouhi B, Cron J. Low-Grade Astrocytoma within a Mature Cystic Teratoma in an Adolescent Patient. Journal Of Pediatric And Adolescent Gynecology 2018, 31: 325-327. PMID: 29107097, DOI: 10.1016/j.jpag.2017.10.005.
- Hui P, Gysler SM, Uduman M, Togun TA, Prado DE, Brambs CE, Nallur S, Schwartz PE, Rutherford TJ, Santin AD, Weidhaas JB, Ratner ES. MicroRNA signatures discriminate between uterine and ovarian serous carcinomas. Human Pathology 2018, 76: 133-140. PMID: 29518404, DOI: 10.1016/j.humpath.2018.02.019.
- McCluggage WG, Judge MJ, Alvarado-Cabrero I, Duggan MA, Horn LC, Hui P, Ordi J, Otis CN, Park KJ, Plante M, Stewart CJR, Wiredu EK, Rous B, Hirschowitz L. Data Set for the Reporting of Carcinomas of the Cervix: Recommendations From the International Collaboration on Cancer Reporting (ICCR). International Journal Of Gynecological Pathology : Official Journal Of The International Society Of Gynecological Pathologists 2018, 37: 205-228. PMID: 28700433, DOI: 10.1097/PGP.0000000000000412.
- Altwerger G, Bonazzoli E, Bellone S, Egawa-Takata T, Menderes G, Pettinella F, Bianchi A, Riccio F, Feinberg J, Zammataro L, Han C, Yadav G, Dugan K, Morneault A, Ponte JF, Buza N, Hui P, Wong S, Litkouhi B, Ratner E, Silasi DA, Huang GS, Azodi M, Schwartz PE, Santin AD. In Vitro and In Vivo Activity of IMGN853, an Antibody-Drug Conjugate Targeting Folate Receptor Alpha Linked to DM4, in Biologically Aggressive Endometrial Cancers. Molecular Cancer Therapeutics 2018, 17: 1003-1011. PMID: 29440294, PMCID: PMC5932245, DOI: 10.1158/1535-7163.MCT-17-0930.
- Zuo T, Wong S, Buza N, Hui P. KRAS mutation of extraovarian implants of serous borderline tumor: prognostic indicator for adverse clinical outcome. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2018, 31: 350-357. PMID: 29027536, DOI: 10.1038/modpathol.2017.121.
- Albright BB, Black JD, Passarelli R, Gysler S, Whicker M, Altwerger G, Menderes G, Buza N, Hui P, Santin AD, Azodi M, Silasi DA, Ratner ES, Litkouhi B, Schwartz PE. Associated characteristics and impact on recurrence and survival of free-floating tumor fragments in the lumen of fallopian tubes in Type I and Type II endometrial cancer. Gynecologic Oncology Reports 2018, 23: 28-33. PMID: 29387776, PMCID: PMC5771964, DOI: 10.1016/j.gore.2018.01.003.
- Boto AN, Hui P. Hormone producing gynecological tumors: pathologic entities and clinical significance. Expert Review Of Endocrinology & Metabolism 2018, 13: 9-24. PMID: 30063444, DOI: 10.1080/17446651.2018.1411799.
- Menderes G, Bonazzoli E, Bellone S, Black J, Predolini F, Pettinella F, Masserdotti A, Zammataro L, Altwerger G, Buza N, Hui P, Wong S, Litkouhi B, Ratner E, Silasi DA, Azodi M, Schwartz PE, Santin AD. SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody-Drug Conjugate, Shows Antitumor Activity in Uterine and Ovarian Carcinosarcoma with HER2/Neu Expression. Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research 2017, 23: 5836-5845. PMID: 28679774, PMCID: PMC5626613, DOI: 10.1158/1078-0432.CCR-16-2862.
- Snir OL, DeJoseph M, Wong S, Buza N, Hui P. Frequent homozygosity in both mature and immature ovarian teratomas: a shared genetic basis of tumorigenesis. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2017, 30: 1467-1475. PMID: 28664933, DOI: 10.1038/modpathol.2017.66.
- Menderes G, Bonazzoli E, Bellone S, Altwerger G, Black JD, Dugan K, Pettinella F, Masserdotti A, Riccio F, Bianchi A, Zammataro L, de Haydu C, Buza N, Hui P, Wong S, Huang GS, Litkouhi B, Ratner E, Silasi DA, Azodi M, Schwartz PE, Santin AD. Superior in vitro and in vivo activity of trastuzumab-emtansine (T-DM1) in comparison to trastuzumab, pertuzumab and their combination in epithelial ovarian carcinoma with high HER2/neu expression. Gynecologic Oncology 2017, 147: 145-152. PMID: 28705408, PMCID: PMC5605415, DOI: 10.1016/j.ygyno.2017.07.009.
- Buza N, Hui P. Immunohistochemistry in Gynecologic Pathology: An Example-Based Practical Update. Archives Of Pathology & Laboratory Medicine 2017, 141: 1052-1071. PMID: 28745567, DOI: 10.5858/arpa.2016-0541-RA.
- Menderes G, Bonazzoli E, Bellone S, Black J, Altwerger G, Masserdotti A, Pettinella F, Zammataro L, Buza N, Hui P, Wong S, Litkouhi B, Ratner E, Silasi DA, Huang GS, Azodi M, Schwartz PE, Santin AD. SYD985, a novel duocarmycin-based HER2-targeting antibody-drug conjugate, shows promising antitumor activity in epithelial ovarian carcinoma with HER2/Neu expression. Gynecologic Oncology 2017, 146: 179-186. PMID: 28473206, PMCID: PMC5533304, DOI: 10.1016/j.ygyno.2017.04.023.
- Hardee S, Prasad ML, Hui P, Dinauer CA, Morotti RA. Pathologic Characteristics, Natural History, and Prognostic Implications of BRAFV600E Mutation in Pediatric Papillary Thyroid Carcinoma. Pediatric And Developmental Pathology : The Official Journal Of The Society For Pediatric Pathology And The Paediatric Pathology Society 2017, 20: 206-212. PMID: 28521635, DOI: 10.1177/1093526616689628.
- Deshmukh U, McAdow M, Black J, Hui P, Azodi M. Isolated port site recurrence of node-negative clinical stage IB1 cervical adenocarcinoma. Gynecologic Oncology Reports 2017, 20: 54-57. PMID: 28331901, PMCID: PMC5348602, DOI: 10.1016/j.gore.2017.03.001.
- Wong S, Hong W, Hui P, Buza N. Comprehensive Analysis of PAX8 Expression in Epithelial Malignancies of the Uterine Cervix. International Journal Of Gynecological Pathology : Official Journal Of The International Society Of Gynecological Pathologists 2017, 36: 101-106. PMID: 27362905, DOI: 10.1097/PGP.0000000000000309.
- Hui P, Buza N, Murphy KM, Ronnett BM. Hydatidiform Moles: Genetic Basis and Precision Diagnosis. Annual Review Of Pathology 2017, 12: 449-485. PMID: 28135560, DOI: 10.1146/annurev-pathol-052016-100237.
- Bellone S, Bignotti E, Lonardi S, Ferrari F, Centritto F, Masserdotti A, Pettinella F, Black J, Menderes G, Altwerger G, Hui P, Lopez S, de Haydu C, Bonazzoli E, Predolini F, Zammataro L, Cocco E, Ferrari F, Ravaggi A, Romani C, Facchetti F, Sartori E, Odicino FE, Silasi DA, Litkouhi B, Ratner E, Azodi M, Schwartz PE, Santin AD. Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro. Gynecologic Oncology 2017, 144: 146-152. PMID: 27894751, PMCID: PMC5183545, DOI: 10.1016/j.ygyno.2016.11.023.
- Zhao S, Bellone S, Lopez S, Thakral D, Schwab C, English DP, Black J, Cocco E, Choi J, Zammataro L, Predolini F, Bonazzoli E, Bi M, Buza N, Hui P, Wong S, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Odicino F, Pecorelli S, Donzelli C, Ardighieri L, Facchetti F, Falchetti M, Silasi DA, Ratner E, Azodi M, Schwartz PE, Mane S, Angioli R, Terranova C, Quick CM, Edraki B, Bilgüvar K, Lee M, Choi M, Stiegler AL, Boggon TJ, Schlessinger J, Lifton RP, Santin AD. Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition. Proceedings Of The National Academy Of Sciences Of The United States Of America 2016, 113: 12238-12243. PMID: 27791010, PMCID: PMC5087050, DOI: 10.1073/pnas.1614120113.
- Snir OL, Buza N, Hui P. Mucinous epithelial tumours arising from ovarian mature teratomas: a tissue genotyping study. Histopathology 2016, 69: 383-92. PMID: 26952875, DOI: 10.1111/his.12959.
- Black J, Menderes G, Bellone S, Schwab CL, Bonazzoli E, Ferrari F, Predolini F, De Haydu C, Cocco E, Buza N, Hui P, Wong S, Lopez S, Ratner E, Silasi DA, Azodi M, Litkouhi B, Schwartz PE, Goedings P, Beusker PH, van der Lee MM, Timmers CM, Dokter WH, Santin AD. SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody-Drug Conjugate, Shows Antitumor Activity in Uterine Serous Carcinoma with HER2/Neu Expression. Molecular Cancer Therapeutics 2016, 15: 1900-9. PMID: 27256376, DOI: 10.1158/1535-7163.MCT-16-0163.
- Cocco E, Lopez S, Black J, Bellone S, Bonazzoli E, Predolini F, Ferrari F, Schwab CL, Menderes G, Zammataro L, Buza N, Hui P, Wong S, Zhao S, Bai Y, Rimm DL, Ratner E, Litkouhi B, Silasi DA, Azodi M, Schwartz PE, Santin AD. Dual CCNE1/PIK3CA targeting is synergistic in CCNE1-amplified/PIK3CA-mutated uterine serous carcinomas in vitro and in vivo. British Journal Of Cancer 2016, 115: 303-11. PMID: 27351214, PMCID: PMC4973158, DOI: 10.1038/bjc.2016.198.
- Levi AW, Bernstein JI, Hui P, Duch K, Schofield K, Chhieng DC. A Comparison of the Roche Cobas HPV Test With the Hybrid Capture 2 Test for the Detection of High-Risk Human Papillomavirus Genotypes. Archives Of Pathology & Laboratory Medicine 2016, 140: 153-7. PMID: 26910220, DOI: 10.5858/arpa.2015-0027-OA.
- Buza N, Ziai J, Hui P. Mismatch repair deficiency testing in clinical practice. Expert Review Of Molecular Diagnostics 2016, 16: 591-604. PMID: 26895074, DOI: 10.1586/14737159.2016.1156533.
- Alomari AK, Glusac EJ, Choi J, Hui P, Seeley EH, Caprioli RM, Watsky KL, Urban J, Lazova R. Congenital nevi versus metastatic melanoma in a newborn to a mother with malignant melanoma - diagnosis supported by sex chromosome analysis and Imaging Mass Spectrometry. Journal Of Cutaneous Pathology 2015, 42: 757-64. PMID: 25989266, DOI: 10.1111/cup.12523.
- Arleo EK, Schwartz PE, Hui P, McCarthy S. Review of Leiomyoma Variants. AJR. American Journal Of Roentgenology 2015, 205: 912-21. PMID: 26397344, DOI: 10.2214/AJR.14.13946.
- Munday WR, Hui P. Heterozygous bone marrow in a homozygous mature ovarian teratoma: a challenge to the germ cell theory or incidental somatic heterotopia? Journal Of Clinical Pathology 2015, 68: 666-9. PMID: 25979987, DOI: 10.1136/jclinpath-2015-202959.
- Ezaldein H, Lott JP, McNiff JM, Hui P, Buza N, Ko CJ. Grading of atypia in genital skin lesions: routine microscopic evaluation and use of p16 immunostaining. Journal Of Cutaneous Pathology 2015, 42: 519-26. PMID: 25951050, DOI: 10.1111/cup.12525.
- Hong W, Abi-Raad R, Alomari AK, Hui P, Buza N. Diagnostic application of KRAS mutation testing in uterine microglandular proliferations. Human Pathology 2015, 46: 1000-5. PMID: 25997988, DOI: 10.1016/j.humpath.2015.03.010.
- Cai G, Bernstein J, Aslanian HR, Hui P, Chhieng D. Endoscopic ultrasound-guided fine-needle aspiration biopsy of autoimmune pancreatitis: diagnostic clues and pitfalls. Journal Of The American Society Of Cytopathology 2015, 4: 211-217. PMID: 31051756, DOI: 10.1016/j.jasc.2015.01.006.
- Perincheri S, Hui P. KRAS mutation testing in clinical practice. Expert Review Of Molecular Diagnostics 2015, 15: 375-84. PMID: 25487540, DOI: 10.1586/14737159.2015.986102.
- Alomari AK, Kelley BJ, Damisah E, Marks A, Hui P, DiLuna M, Vortmeyer A. Craniopharyngioma arising in a Rathke's cleft cyst: case report. Journal Of Neurosurgery. Pediatrics 2015, 15: 250-4. PMID: 25555112, DOI: 10.3171/2014.11.PEDS14370.
- Carr RJ, Hui P, Buza N. Intravenous leiomyomatosis revisited: an experience of 14 cases at a single medical center. International Journal Of Gynecological Pathology : Official Journal Of The International Society Of Gynecological Pathologists 2015, 34: 169-76. PMID: 25675187, DOI: 10.1097/PGP.0000000000000127.
- Zheng X, Wu B, Buza N, Hui P. [Ancillary techniques in refining the diagnosis of hydatidiform mole]. Zhonghua Bing Li Xue Za Zhi Chinese Journal Of Pathology 2015, 44: 15-20. PMID: 25765025.
- Nicoletti R, Lopez S, Bellone S, Cocco E, Schwab CL, Black JD, Centritto F, Zhu L, Bonazzoli E, Buza N, Hui P, Mezzanzanica D, Canevari S, Schwartz PE, Rutherford TJ, Santin AD. T-DM1, a novel antibody-drug conjugate, is highly effective against uterine and ovarian carcinosarcomas overexpressing HER2. Clinical & Experimental Metastasis 2015, 32: 29-38. PMID: 25398397, PMCID: PMC4310789, DOI: 10.1007/s10585-014-9688-8.
- Adeniran AJ, Hui P. Best practice of BRAF V600E mutation testing for the diagnosis and management of thyroid cancers. Expert Review Of Endocrinology & Metabolism 2014, 9: 571-577. PMID: 30736195, DOI: 10.1586/17446651.2014.951635.
- English DP, Bellone S, Schwab CL, Bortolomai I, Bonazzoli E, Cocco E, Buza N, Hui P, Lopez S, Ratner E, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Santin AD. T-DM1, a novel antibody-drug conjugate, is highly effective against primary HER2 overexpressing uterine serous carcinoma in vitro and in vivo. Cancer Medicine 2014, 3: 1256-65. PMID: 24890382, PMCID: PMC4302675, DOI: 10.1002/cam4.274.
- Buza N, Xu F, Wu W, Carr RJ, Li P, Hui P. Recurrent chromosomal aberrations in intravenous leiomyomatosis of the uterus: high-resolution array comparative genomic hybridization study. Human Pathology 2014, 45: 1885-92. PMID: 25033729, DOI: 10.1016/j.humpath.2014.05.010.
- Buza N, Hui P. Egg donor pregnancy: a potential pitfall in DNA genotyping diagnosis of hydatidiform moles. International Journal Of Gynecological Pathology : Official Journal Of The International Society Of Gynecological Pathologists 2014, 33: 507-10. PMID: 25083967, DOI: 10.1097/PGP.0b013e3182a1028b.
- Ahmad AK, Hui P, Litkouhi B, Azodi M, Rutherford T, McCarthy S, Xu ML, Schwartz PE, Ratner E. Institutional review of primary non-hodgkin lymphoma of the female genital tract: a 33-year experience. International Journal Of Gynecological Cancer : Official Journal Of The International Gynecological Cancer Society 2014, 24: 1250-5. PMID: 25010039, PMCID: PMC8139417, DOI: 10.1097/IGC.0000000000000201.
- Abi-Raad R, Alomari A, Hui P, Buza N. Mitotically active microglandular hyperplasia of the cervix: a case series with implications for the differential diagnosis. International Journal Of Gynecological Pathology : Official Journal Of The International Society Of Gynecological Pathologists 2014, 33: 524-30. PMID: 25083971, DOI: 10.1097/PGP.0000000000000086.
- Alomari A, Abi-Raad R, Buza N, Hui P. Frequent KRAS mutation in complex mucinous epithelial lesions of the endometrium. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2014, 27: 675-80. PMID: 24186144, DOI: 10.1038/modpathol.2013.186.
- Buza N, Hui P. Immunohistochemistry and other ancillary techniques in the diagnosis of gestational trophoblastic diseases. Seminars In Diagnostic Pathology 2014, 31: 223-32. PMID: 24907943, DOI: 10.1053/j.semdp.2014.03.004.
- Schwartz PE, Hui P, McCarthy S. Hormonal therapy for aggressive angiomyxoma: a case report and proposed management algorithm. Journal Of Lower Genital Tract Disease 2014, 18: E55-61. PMID: 24402356, DOI: 10.1097/LGT.0b013e3182a22019.
- Much M, Buza N, Hui P. Tissue identity testing of cancer by short tandem repeat polymorphism: pitfalls of interpretation in the presence of microsatellite instability. Human Pathology 2014, 45: 549-55. PMID: 24444463, DOI: 10.1016/j.humpath.2013.10.022.
- Schalper KA, Kumar S, Hui P, Rimm DL, Gershkovich P. A retrospective population-based comparison of HER2 immunohistochemistry and fluorescence in situ hybridization in breast carcinomas: impact of 2007 American Society of Clinical Oncology/College of American Pathologists criteria. Archives Of Pathology & Laboratory Medicine 2014, 138: 213-9. PMID: 24164555, DOI: 10.5858/arpa.2012-0617-OA.
- Hui P. Next generation sequencing: chemistry, technology and applications. Topics In Current Chemistry 2014, 336: 1-18. PMID: 22648865, DOI: 10.1007/128_2012_329.
- Buza N, Rutherford T, Hui P. Genotyping diagnosis of nongestational choriocarcinoma involving fallopian tube and broad ligament: a case study. International Journal Of Gynecological Pathology : Official Journal Of The International Society Of Gynecological Pathologists 2014, 33: 58-63. PMID: 24300537, DOI: 10.1097/PGP.0b013e31827cd386.
- Zheng XZ, Hui P, Chang B, Gao ZB, Li Y, Wu BQ, Zhang B. STR DNA genotyping of hydatidiform moles in South China. International Journal Of Clinical And Experimental Pathology 2014, 7: 4704-19. PMID: 25197342, PMCID: PMC4152032.
- Bernstein J, Virk RK, Hui P, Prasad A, Westra WH, Tallini G, Adeniran AJ, Udelsman R, Sasaki CT, Roman SA, Sosa JA, Prasad ML. Tall cell variant of papillary thyroid microcarcinoma: clinicopathologic features with BRAF(V600E) mutational analysis. Thyroid : Official Journal Of The American Thyroid Association 2013, 23: 1525-31. PMID: 23682579, DOI: 10.1089/thy.2013.0154.
- Orsaria M, Khelifa S, Buza N, Kamath A, Hui P. Chromosome 17 polysomy: correlation with histological parameters and HER2NEU gene amplification. Journal Of Clinical Pathology 2013, 66: 1070-5. PMID: 23908451, DOI: 10.1136/jclinpath-2013-201506.
- Buza N, Hui P. Marked heterogeneity of HER2/NEU gene amplification in endometrial serous carcinoma. Genes, Chromosomes & Cancer 2013, 52: 1178-86. PMID: 24123408, DOI: 10.1002/gcc.22113.
- Buza N, English DP, Santin AD, Hui P. Toward standard HER2 testing of endometrial serous carcinoma: 4-year experience at a large academic center and recommendations for clinical practice. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2013, 26: 1605-12. PMID: 23765245, DOI: 10.1038/modpathol.2013.113.
- Cai G, Wong R, Chhieng D, Levy GH, Gettinger SN, Herbst RS, Puchalski JT, Homer RJ, Hui P. Identification of EGFR mutation, KRAS mutation, and ALK gene rearrangement in cytological specimens of primary and metastatic lung adenocarcinoma. Cancer Cytopathology 2013, 121: 500-7. PMID: 23495083, DOI: 10.1002/cncy.21288.
- Bossuyt V, Buza N, Ngo NT, Much MA, Asis MC, Schwartz PE, Hui P. Cancerous 'floater': a lesson learned about tissue identity testing, endometrial cancer and microsatellite instability. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2013, 26: 1264-9. PMID: 23558568, DOI: 10.1038/modpathol.2013.63.
- Gunal A, Hui P, Kilic S, Xu R, Jain D, Mitchell K, Robert M, Kenney B. KRAS mutations are associated with specific morphologic features in colon cancer. Journal Of Clinical Gastroenterology 2013, 47: 509-14. PMID: 23090042, DOI: 10.1097/MCG.0b013e3182703030.
- Alomari A, Hui P, Xu M. Composite peripheral T-cell lymphoma not otherwise specified, and B-cell small lymphocytic lymphoma presenting with hemophagocytic lymphohistiocytosis. International Journal Of Surgical Pathology 2013, 21: 303-8. PMID: 23129836, DOI: 10.1177/1066896912464047.
- Bao F, Chen GR, Hui P, Cai GP. [Diagnosis, histopathologic grading and prognostic moleculer marker analysis in patients with pancreatic neuroendocrine neoplasm]. Zhonghua Bing Li Xue Za Zhi Chinese Journal Of Pathology 2013, 42: 426-32. PMID: 24060085, DOI: 10.3760/cma.j.issn.0529-5807.2013.06.016.
- Buza N, Hui P. Partial hydatidiform mole: histologic parameters in correlation with DNA genotyping. International Journal Of Gynecological Pathology : Official Journal Of The International Society Of Gynecological Pathologists 2013, 32: 307-15. PMID: 23518914, DOI: 10.1097/PGP.0b013e3182626011.
- Liu M, Mor G, Cheng H, Xiang X, Hui P, Rutherford T, Yin G, Rimm DL, Holmberg J, Alvero A, Silasi DA. High frequency of putative ovarian cancer stem cells with CD44/CK19 coexpression is associated with decreased progression-free intervals in patients with recurrent epithelial ovarian cancer. Reproductive Sciences (Thousand Oaks, Calif.) 2013, 20: 605-15. PMID: 23171677, PMCID: PMC3635069, DOI: 10.1177/1933719112461183.
- Zhong H, Liu Y, Talmor M, Wu B, Hui P. Deparaffinization and lysis by hydrothermal pressure (pressure cooking) coupled with chaotropic salt column purification: a rapid and efficient method of DNA extraction from formalin-fixed paraffin-embedded tissue. Diagnostic Molecular Pathology : The American Journal Of Surgical Pathology, Part B 2013, 22: 52-8. PMID: 23370427, DOI: 10.1097/PDM.0b013e318263f092.
- Zhao S, Choi M, Overton JD, Bellone S, Roque DM, Cocco E, Guzzo F, English DP, Varughese J, Gasparrini S, Bortolomai I, Buza N, Hui P, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Carrara L, Pecorelli S, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Stiegler AL, Mane S, Boggon TJ, Schlessinger J, Lifton RP, Santin AD. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Proceedings Of The National Academy Of Sciences Of The United States Of America 2013, 110: 2916-21. PMID: 23359684, PMCID: PMC3581983, DOI: 10.1073/pnas.1222577110.
- Liu Y, Wu BQ, Zhong HH, Hui P, Fang WG. Screening for EGFR and KRAS mutations in non-small cell lung carcinomas using DNA extraction by hydrothermal pressure coupled with PCR-based direct sequencing. International Journal Of Clinical And Experimental Pathology 2013, 6: 1880-9. PMID: 24040454, PMCID: PMC3759496.
- Virk RK, Van Dyke AL, Finkelstein A, Prasad A, Gibson J, Hui P, Theoharis CG, Carling T, Roman SA, Sosa JA, Udelsman R, Prasad ML. BRAFV600E mutation in papillary thyroid microcarcinoma: a genotype-phenotype correlation. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2013, 26: 62-70. PMID: 22918165, DOI: 10.1038/modpathol.2012.152.
- Waldron-Lynch F, Inzucchi SE, Menard L, Tai N, Preston-Hurlburt P, Hui P, McClaskey J, Hagopian WA, Meffre E, Marks PW, Wen L, Herold KC. Relapsing and remitting severe hypoglycemia due to a monoclonal anti-insulin antibody heralding a case of multiple myeloma. The Journal Of Clinical Endocrinology And Metabolism 2012, 97: 4317-23. PMID: 23074233, PMCID: PMC3513536, DOI: 10.1210/jc.2012-2388.
- Hui P, Liu Y. [Genetic basis of molar pregnancy]. Zhonghua Bing Li Xue Za Zhi Chinese Journal Of Pathology 2012, 41: 721-4. PMID: 23302329, DOI: 10.3760/cma.j.issn.0529-5807.2012.11.001.
- Oktay MH, Hui P. Molecular pathology as the driving force for personalized oncology. Expert Review Of Molecular Diagnostics 2012, 12: 811-3. PMID: 23249199, DOI: 10.1586/erm.12.121.
- Cai G, Mahooti S, Lipata FM, Chhieng D, Hui P. Diagnostic value of K-ras mutation analysis for pancreaticobiliary cytology specimens with indeterminate diagnosis. Cancer Cytopathology 2012, 120: 313-8. PMID: 22367918, DOI: 10.1002/cncy.21188.
- Levi AW, Beckman D, Hui P, Schofield K, Harigopal M, Chhieng DC. Comparing two methods of detection for Chlamydia trachomatis in liquid-based Papanicolaou tests. American Journal Of Clinical Pathology 2012, 138: 236-40. PMID: 22904135, DOI: 10.1309/AJCP2B7XQTCNAMJP.
- Finkelstein A, Levy GH, Hui P, Prasad A, Virk R, Chhieng DC, Carling T, Roman SA, Sosa JA, Udelsman R, Theoharis CG, Prasad ML. Papillary thyroid carcinomas with and without BRAF V600E mutations are morphologically distinct. Histopathology 2012, 60: 1052-9. PMID: 22335197, DOI: 10.1111/j.1365-2559.2011.04149.x.
- Guzzo F, Bellone S, Buza N, Hui P, Carrara L, Varughese J, Cocco E, Betti M, Todeschini P, Gasparrini S, Schwartz PE, Rutherford TJ, Angioli R, Pecorelli S, Santin AD. HER2/neu as a potential target for immunotherapy in gynecologic carcinosarcomas. International Journal Of Gynecological Pathology : Official Journal Of The International Society Of Gynecological Pathologists 2012, 31: 211-21. PMID: 22498937, PMCID: PMC3366047, DOI: 10.1097/PGP.0b013e31823bb24d.
- Ziai J, Hui P. BRAF mutation testing in clinical practice. Expert Review Of Molecular Diagnostics 2012, 12: 127-38. PMID: 22369373, DOI: 10.1586/erm.12.1.
- Todeschini P, Cocco E, Bellone S, Varughese J, Lin K, Carrara L, Guzzo F, Buza N, Hui P, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD. Her2/neu extracellular domain shedding in uterine serous carcinoma: implications for immunotherapy with trastuzumab. British Journal Of Cancer 2011, 105: 1176-82. PMID: 21915118, PMCID: PMC3208497, DOI: 10.1038/bjc.2011.369.
- Levi AW, Harigopal M, Hui P, Schofield K, Chhieng DC. Use of high-risk human papillomavirus testing in patients with low-grade squamous intraepithelial lesions. Cancer Cytopathology 2011, 119: 228-34. PMID: 21732551, DOI: 10.1002/cncy.20172.
- Adeniran AJ, Theoharis C, Hui P, Prasad ML, Hammers L, Carling T, Udelsman R, Chhieng DC. Reflex BRAF testing in thyroid fine-needle aspiration biopsy with equivocal and positive interpretation: a prospective study. Thyroid : Official Journal Of The American Thyroid Association 2011, 21: 717-23. PMID: 21568726, DOI: 10.1089/thy.2011.0021.
- Levi AW, Harigopal M, Hui P, Schofield K, Chhieng DC. Comparison of Affirm VPIII and Papanicolaou tests in the detection of infectious vaginitis. American Journal Of Clinical Pathology 2011, 135: 442-7. PMID: 21350100, DOI: 10.1309/AJCP7TBN5VZUGLZU.
- Varughese J, Hui P, Lu L, Yu H, Schwartz PE. Clear cell cancer of the uterine corpus: the association of clinicopathologic parameters and treatment on disease progression. Journal Of Oncology 2011, 2011: 628084. PMID: 22187554, PMCID: PMC3236522, DOI: 10.1155/2011/628084.
- Steffensen KD, Alvero AB, Yang Y, Waldstrøm M, Hui P, Holmberg JC, Silasi DA, Jakobsen A, Rutherford T, Mor G. Prevalence of epithelial ovarian cancer stem cells correlates with recurrence in early-stage ovarian cancer. Journal Of Oncology 2011, 2011: 620523. PMID: 21904548, PMCID: PMC3166719, DOI: 10.1155/2011/620523.
- Adeniran AJ, Hui P, Chhieng DC, Prasad ML, Schofield K, Theoharis C. BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance. Acta Cytologica 2011, 55: 570-5. PMID: 22156468, DOI: 10.1159/000333274.
- Liu CR, Hui P. [Molecular diagnosis of molar pregnancy]. Zhonghua Bing Li Xue Za Zhi Chinese Journal Of Pathology 2011, 40: 6-10. PMID: 21429351.
- Hui P. Molecular diagnosis of gestational trophoblastic disease. Expert Review Of Molecular Diagnostics 2010, 10: 1023-34. PMID: 21080819, DOI: 10.1586/erm.10.93.
- Ou-Yang RJ, Hui P, Yang XJ, Zynger DL. Expression of glypican 3 in placental site trophoblastic tumor. Diagnostic Pathology 2010, 5: 64. PMID: 20868507, PMCID: PMC2954974, DOI: 10.1186/1746-1596-5-64.
- Ratner ES, Tuck D, Richter C, Nallur S, Patel RM, Schultz V, Hui P, Schwartz PE, Rutherford TJ, Weidhaas JB. MicroRNA signatures differentiate uterine cancer tumor subtypes. Gynecologic Oncology 2010, 118: 251-7. PMID: 20542546, PMCID: PMC2918705, DOI: 10.1016/j.ygyno.2010.05.010.
- Ratner E, Lu L, Boeke M, Barnett R, Nallur S, Chin LJ, Pelletier C, Blitzblau R, Tassi R, Paranjape T, Hui P, Godwin AK, Yu H, Risch H, Rutherford T, Schwartz P, Santin A, Matloff E, Zelterman D, Slack FJ, Weidhaas JB. A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk. Cancer Research 2010, 70: 6509-15. PMID: 20647319, PMCID: PMC2923587, DOI: 10.1158/0008-5472.CAN-10-0689.
- Siddon A, Hui P. Glial heterotopia of the uterine cervix: DNA genotyping confirmation of its fetal origin. International Journal Of Gynecological Pathology : Official Journal Of The International Society Of Gynecological Pathologists 2010, 29: 394-7. PMID: 20567155, DOI: 10.1097/PGP.0b013e3181c5a7e8.
- Richter CE, Hui P, Buza N, Silasi DA, Azodi M, Santin AD, Schwartz PE, Rutherford TJ. HER-2/NEU overexpression in vulvar Paget disease: the Yale experience. Journal Of Clinical Pathology 2010, 63: 544-7. PMID: 20418225, DOI: 10.1136/jcp.2010.077446.
- Lipata F, Parkash V, Talmor M, Bell S, Chen S, Maric V, Hui P. Precise DNA genotyping diagnosis of hydatidiform mole. Obstetrics And Gynecology 2010, 115: 784-794. PMID: 20308840, DOI: 10.1097/AOG.0b013e3181d489ec.
- El-Sahwi K, Bellone S, Cocco E, Cargnelutti M, Casagrande F, Bellone M, Abu-Khalaf M, Buza N, Tavassoli FA, Hui P, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD. In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma. British Journal Of Cancer 2010, 102: 134-43. PMID: 19920829, PMCID: PMC2813756, DOI: 10.1038/sj.bjc.6605448.
- El-Sahwi K, Bellone S, Cocco E, Casagrande F, Bellone M, Abu-Khalaf M, Buza N, Tavassoli FA, Hui P, Rüttinger D, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD. Overexpression of EpCAM in uterine serous papillary carcinoma: implications for EpCAM-specific immunotherapy with human monoclonal antibody adecatumumab (MT201). Molecular Cancer Therapeutics 2010, 9: 57-66. PMID: 20053761, PMCID: PMC2806489, DOI: 10.1158/1535-7163.MCT-09-0675.
- Yan Z, Hui P. Minimal uterine serous carcinoma with extrauterine tumor of identical morphology: an immunohistochemical study of 13 cases. Applied Immunohistochemistry & Molecular Morphology : AIMM / Official Publication Of The Society For Applied Immunohistochemistry 2010, 18: 75-9. PMID: 19956063, DOI: 10.1097/PAI.0b013e3181b1d10e.
- Xu M, Schwartz P, Rutherford T, Azodi M, Santin A, Silasi D, Martel M, Hui P. HER-2/neu receptor gene status in endometrial carcinomas: a tissue microarray study. Histopathology 2010, 56: 269-73. PMID: 20102407, DOI: 10.1111/j.1365-2559.2009.03464.x.
- Baehring J, Hui P, Piepmeier J, Bannykh SI. Anaplastic oligoastrocytoma in Turcot syndrome. Journal Of Neuro-oncology 2009, 95: 293-298. PMID: 19495563, DOI: 10.1007/s11060-009-9928-y.
- Mac MT, Chung F, Lin F, Hui P, Balzer BL, Wang HL. Expression of hepatocyte antigen in small intestinal epithelium and adenocarcinoma. American Journal Of Clinical Pathology 2009, 132: 80-5. PMID: 19864237, DOI: 10.1309/AJCPUD0P5NQBOYPK.
- Xu ML, Yang B, Carcangiu ML, Hui P. Epithelioid trophoblastic tumor: comparative genomic hybridization and diagnostic DNA genotyping. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2009, 22: 232-8. PMID: 18820674, DOI: 10.1038/modpathol.2008.165.
- Galan A, Hui P, McNiff JM. Absence of human herpesvirus 8 in pemphigus and bullous pemphigoid. International Journal Of Clinical And Experimental Pathology 2009, 2: 456-62. PMID: 19294004, PMCID: PMC2655157.
- Xu Y, Dotto J, Hui Y, Lawton K, Schofield K, Hui P. High grade cervical intraepithelial neoplasia and viral load of high-risk human papillomavirus: significant correlations in patients of 22 years old or younger. International Journal Of Clinical And Experimental Pathology 2009, 2: 169-75. PMID: 19079652, PMCID: PMC2583634.
- Dotto J, Hui P. Lack of genetic association between exaggerated placental site reaction and placental site trophoblastic tumor. International Journal Of Gynecological Pathology : Official Journal Of The International Society Of Gynecological Pathologists 2008, 27: 562-7. PMID: 18753963, DOI: 10.1097/PGP.0b013e31816d1d00.
- He H, Luthringer DJ, Hui P, Lau SK, Weiss LM, Chu PG. Expression of CD56 and WT1 in ovarian stroma and ovarian stromal tumors. The American Journal Of Surgical Pathology 2008, 32: 884-90. PMID: 18425046, DOI: 10.1097/PAS.0b013e3181609d59.
- Bifulco C, Johnson C, Hao L, Kermalli H, Bell S, Hui P. Genotypic analysis of hydatidiform mole: an accurate and practical method of diagnosis. The American Journal Of Surgical Pathology 2008, 32: 445-51. PMID: 18300805, DOI: 10.1097/PAS.0b013e3181520034.
- De Stefano D, Li P, Xiang B, Hui P, Zambrano E. Pulmonary atresia with intact ventricular septum (PA-IVS) in monozygotic twins. American Journal Of Medical Genetics. Part A 2008, 146A: 525-8. PMID: 18203206, DOI: 10.1002/ajmg.a.32160.
- Makhlouf HR, Ahrens W, Agarwal B, Dow N, Marshalleck JJ, Lee EL, Dotto JE, Hui P, Sobin LH, Oliveira A, Miettinen M. Synovial sarcoma of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 10 cases. The American Journal Of Surgical Pathology 2008, 32: 275-81. PMID: 18223331, DOI: 10.1097/PAS.0b013e31812e6a58.
- Dotto J, Mezzetti T, Hui P. Primary or secondary? Genotyping confirmation of an ovarian primary carcinoid tumor. International Journal Of Gynecological Pathology : Official Journal Of The International Society Of Gynecological Pathologists 2008, 27: 33-6. PMID: 18156971, DOI: 10.1097/pgp.0b13e318053df4.
- Baehring JM, Landry ML, Cooper D, Hui P, Bannykh S. CSF IgH gene rearrangement analysis in isolated post-transplant lymphoproliferative disorder of the central nervous system. Journal Of Neuro-oncology 2008, 86: 57-60. PMID: 17909942, DOI: 10.1007/s11060-007-9429-9.
- Zhang MQ, Lin F, Hui P, Chen ZM, Ritter JH, Wang HL. Expression of mucins, SIMA, villin, and CDX2 in small-intestinal adenocarcinoma. American Journal Of Clinical Pathology 2007, 128: 808-16. PMID: 17951204, DOI: 10.1309/JAF3KVGJHQCJ1QF9.
- Hui P, Wang HL, Chu P, Yang B, Huang J, Baergen RN, Sklar J, Yang XJ, Soslow RA. Absence of Y chromosome in human placental site trophoblastic tumor. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2007, 20: 1055-60. PMID: 17643092, DOI: 10.1038/modpathol.3800941.
- Hui P. [Pathogenesis of endometrial cancer: clinicopathologic implications]. Zhonghua Bing Li Xue Za Zhi Chinese Journal Of Pathology 2006, 35: 705-7. PMID: 17374250.
- Patton KT, Cheng L, Papavero V, Blum MG, Yeldandi AV, Adley BP, Luan C, Diaz LK, Hui P, Yang XJ. Benign metastasizing leiomyoma: clonality, telomere length and clinicopathologic analysis. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2006, 19: 130-40. PMID: 16357844, DOI: 10.1038/modpathol.3800504.
- Fadare O, Parkash V, Carcangiu ML, Hui P. Epithelioid trophoblastic tumor: clinicopathological features with an emphasis on uterine cervical involvement. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2006, 19: 75-82. PMID: 16258513, DOI: 10.1038/modpathol.3800485.
- Xing M, Westra WH, Tufano RP, Cohen Y, Rosenbaum E, Rhoden KJ, Carson KA, Vasko V, Larin A, Tallini G, Tolaney S, Holt EH, Hui P, Umbricht CB, Basaria S, Ewertz M, Tufaro AP, Califano JA, Ringel MD, Zeiger MA, Sidransky D, Ladenson PW. BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. The Journal Of Clinical Endocrinology And Metabolism 2005, 90: 6373-9. PMID: 16174717, DOI: 10.1210/jc.2005-0987.
- Hui P, Fedoriw G. Recurrent endometrial stromal tumors with smooth-muscle differentiation and a protracted clinical course. Nature Clinical Practice. Oncology 2005, 2: 588-93, quiz. PMID: 16270099, DOI: 10.1038/ncponc0340.
- Hui P, Li N, Johnson C, De Wever I, Sciot R, Manfioletti G, Tallini G. HMGA proteins in malignant peripheral nerve sheath tumor and synovial sarcoma: preferential expression of HMGA2 in malignant peripheral nerve sheath tumor. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2005, 18: 1519-26. PMID: 16056249, DOI: 10.1038/modpathol.3800464.
- Yatsula B, Lin S, Read AJ, Poholek A, Yates K, Yue D, Hui P, Perkins AS. Identification of binding sites of EVI1 in mammalian cells. The Journal Of Biological Chemistry 2005, 280: 30712-22. PMID: 16006653, DOI: 10.1074/jbc.M504293200.
- Kelly MG, O'malley DM, Hui P, McAlpine J, Yu H, Rutherford TJ, Azodi M, Schwartz PE. Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy. Gynecologic Oncology 2005, 98: 353-9. PMID: 16005947, DOI: 10.1016/j.ygyno.2005.06.012.
- Fadare O, Parkash V, Yilmaz Y, Mariappan MR, Ma L, Hileeto D, Qumsiyeh MB, Hui P. Correction: Perivascular epithelioid cell tumor (PEComa) of the uterine cervix associated with intraabdominal "PEComatosis": A clinicopathological study with comparative genomic hybridization analysis. World Journal Of Surgical Oncology 2005, 3: 25. PMID: 15869711, PMCID: PMC1097764, DOI: 10.1186/1477-7819-3-25.
- Hui P, Martel M, Parkash V. Gestational trophoblastic diseases: recent advances in histopathologic diagnosis and related genetic aspects. Advances In Anatomic Pathology 2005, 12: 116-25. PMID: 15900112, DOI: 10.1097/01.pap.0000163960.11107.73.
- Ma L, Kowalski D, Javed K, Hui P. Atypical angiomyolipoma of kidney in a patient with tuberous sclerosis: a case report with p53 gene mutation analysis. Archives Of Pathology & Laboratory Medicine 2005, 129: 676-9. PMID: 15859641, DOI: 10.5858/2005-129-0676-AAOKIA.
- Hui P, Kelly M, O'Malley DM, Tavassoli F, Schwartz PE. Minimal uterine serous carcinoma: a clinicopathological study of 40 cases. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2005, 18: 75-82. PMID: 15389257, DOI: 10.1038/modpathol.3800271.
- Kelly MG, O'Malley D, Hui P, McAlpine J, Dziura J, Rutherford TJ, Azodi M, Chambers SK, Schwartz PE. Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation. Gynecologic Oncology 2004, 95: 469-73. PMID: 15581948, DOI: 10.1016/j.ygyno.2004.08.030.
- Fadare O, Parkash V, Yilmaz Y, Mariappan MR, Ma L, Hileeto D, Qumsiyeh MB, Hui P. Perivascular epithelioid cell tumor (PEComa) of the uterine cervix associated with intraabdominal "PEComatosis": A clinicopathological study with comparative genomic hybridization analysis. World Journal Of Surgical Oncology 2004, 2: 35. PMID: 15494070, PMCID: PMC527874, DOI: 10.1186/1477-7819-2-35.
- Bhattacharjee P, Hui P, McNiff J. Human herpesvirus-8 is not associated with angiolymphoid hyperplasia with eosinophilia. Journal Of Cutaneous Pathology 2004, 31: 612-5. PMID: 15330993, DOI: 10.1111/j.0303-6987.2004.00240.x.
- Li N, McNiff J, Hui P, Manfioletti G, Tallini G. Differential expression of HMGA1 and HMGA2 in dermatofibroma and dermatofibrosarcoma protuberans: potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity. The American Journal Of Dermatopathology 2004, 26: 267-72. PMID: 15249855, DOI: 10.1097/00000372-200408000-00001.
- Zhang SS, Wei J, Qin H, Zhang L, Xie B, Hui P, Deisseroth A, Barnstable CJ, Fu XY. STAT3-mediated signaling in the determination of rod photoreceptor cell fate in mouse retina. Investigative Ophthalmology & Visual Science 2004, 45: 2407-12. PMID: 15223824, DOI: 10.1167/iovs.04-0003.
- Hui P, Riba A, Pejovic T, Johnson T, Baergen RN, Ward D. Comparative genomic hybridization study of placental site trophoblastic tumour: a report of four cases. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2004, 17: 248-51. PMID: 14657956, DOI: 10.1038/modpathol.3800025.
- Hui P, Howe JG, Crouch J, Nimmakayalu M, Qumsiyeh MB, Tallini G, Flynn SD, Smith BR. Real-time quantitative RT-PCR of cyclin D1 mRNA in mantle cell lymphoma: comparison with FISH and immunohistochemistry. Leukemia & Lymphoma 2003, 44: 1385-94. PMID: 12952233, DOI: 10.1080/1042819031000079168.
- Hui P, Glusac EJ, Sinard JH, Perkins AS. Clonal analysis of cutaneous fibrous histiocytoma (dermatofibroma). Journal Of Cutaneous Pathology 2002, 29: 385-9. PMID: 12139632, DOI: 10.1034/j.1600-0560.2002.290701.x.
- Fusco A, Chiappetta G, Hui P, Garcia-Rostan G, Golden L, Kinder BK, Dillon DA, Giuliano A, Cirafici AM, Santoro M, Rosai J, Tallini G. Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer. The American Journal Of Pathology 2002, 160: 2157-67. PMID: 12057919, PMCID: PMC1850819, DOI: 10.1016/S0002-9440(10)61164-9.
- Tang LH, Hui P, Garcia-Tsao G, Salem RR, Jain D. Multiple angiomyolipomata of the liver: a case report. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc 2002, 15: 167-71. PMID: 11850546, DOI: 10.1038/modpathol.3880509.
- Zambrano E, Marshalko SJ, Jaffe CC, Hui P. Isolated noncompaction of the ventricular myocardium: clinical and molecular aspects of a rare cardiomyopathy. Laboratory Investigation; A Journal Of Technical Methods And Pathology 2002, 82: 117-22. PMID: 11850525, DOI: 10.1038/labinvest.3780404.
- Hui P, Perkins A, Glusac E. Assessment of clonality in melanocytic nevi. Journal Of Cutaneous Pathology 2001, 28: 140-4. PMID: 11168766.
- Hui P, Parkash V, Perkins AS, Carcangiu ML. Pathogenesis of placental site trophoblastic tumor may require the presence of a paternally derived X chromosome. Laboratory Investigation; A Journal Of Technical Methods And Pathology 2000, 80: 965-72. PMID: 10879746, DOI: 10.1038/labinvest.3780099.